John E. Hall

John E. Hall

Chair

Department:
SOM-Physiology & Biophysics

Email:
jehall@umc.edu

Work Phone:
(601) 984-1801

Education

Michigan State University, PhD, Physiology1974
U.S. Army, Military Service, Electronics/ Engineering1970
Kent State University, BS, Biology/Chemistry1968
Smithville High School, High School Diploma, General1964

Current Positions

Founding Director, Mississippi Center for Obesity Research, School of Medicine07/2013 - Present
Arthur C. Guyton Professor and Chair, School of Medicine, Department of Physiology And Biophysics1989 - Present
Professor, School of Medicine, Department of Physiology And Biophysics1982 - Present
Member of Graduate Faculty, School of Medicine, Department of Physiology And Biophysics1977 - Present
The University of Mississippi Medical Center
Jackson, Mississippi 39216

Academic Appointments or Other Previous Appointments

Associate Vice Chancellor for Research, University of Mississippi Medical Center, School of Medicine2005 - 06/2013
Founding Director, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics1996 - 2009
Vice-Chairman, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics1988 - 1989
Director of Graduate Program, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics1980 - 1993
Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics1979 - 1982
Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics1976 - 1979
Instructor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics1975 - 1976
Postdoctoral Fellow, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics1974 - 1976
Graduate Teaching Assistant, Michigan State University, School of Graduate, Department of Physiology And Biophysics1973 - 1974
Graduate Student, Michigan State University, School of Graduate, Department of Physiology And Biophysics1970 - 1973

Sponsored Program Funding

Extramural, Role of Renal Nerves in Obesity-Induced Hypertension, St. Jude Medical, Inc.07/2010 - 06/2012
Extramural, Non-Invasive Hemodynamic Monitoring, National Institutes of Health06/2010 - 07/2012
Extramural, Cardiovascular Dynamics and Their Control (minority supplement award), National Institutes of Health03/2009 - 11/2012
Extramural, Canadian Institutes of Health Research Fellowship Award for Dr. Shereen Hamza, Canadian Institutes of Health01/2009 - 12/2012
Extramural, Mechanisms in Obesity-Induced Renal Injury - postdoctoral fellowship award for Shankar Munusamy, American Heart Association01/2009 - 12/2011
Extramural, Cardiovascular Dynamics and their Control, National Institutes of Health12/2008 - 11/2013
Extramural, Blockade of Soluble Epoxide Hydrolase in Obesity Hypertension, ARETE Therapeutics08/2008 - 07/2009
Extramural, Chronic Metabolic Effects of Blocking Soluble Epoxide Hydrolase, ARETE Therapeutics06/2008 - 07/2009
Extramural, 11B-HSD1 inhibition in hypertension, Merck & Company, Inc.02/2008 - 01/2009
Extramural, Mechanisms of Obesity-Induced Renal Injury - postdoctoral fellowship award for Elizabeth Brandon, National Institutes of Health01/2007 - 12/2010
Extramural, Distinguished Lecture Series, Robert M. Hearin Support Foundation09/2006 - 08/2012
Extramural, Physician Scientist Training Program, Robert M. Hearin Support Foundation09/2006 - 08/2012
Extramural, Jackson Cardiovascular-Renal Meeting, Robert M. Hearin Support Foundation09/2006 - 08/2009
Extramural, Medical Research Scholars Program, Robert M. Hearin Support Foundation07/2006 - 06/2012
Extramural, Postdoctoral Fellowship Program, Robert M. Hearin Support Foundation07/2006 - 06/2009
Extramural, Cardiovascular-Renal Meeting, Robert M. Hearin Foundation01/2006 - 12/2010
Extramural, Postdoctoral Fellows Training Program, Robert M. Hearin Foundation01/2006 - 12/2010
Extramural, Blockade of Soluble Epoxide Hydrolase-a Novel Anti-hypertensive Therapy, ARETE Therapeutics01/2006 - 12/2007
Extramural, Novartis Institutes for Biomedical Research, Novartis07/2005 - 07/2008
Extramural, Jackson Heart Study, National Institutes of Health01/2005 - 12/2013
Extramural, Pfizer Global Research & Development, Pfizer01/2004 - 12/2006
Extramural, Role of the Melanocortin-4 Receptor in Obesity Hypertension - postdoctoral fellowship award for Lakshmi Tallam, American Heart Association01/2004 - 12/2006
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health01/2003 - 12/2008
Extramural, Role of Melanocortin & Sympathetic Nervous Systems in Mediating the Actions of Leptin in Type-1 Diabetes - postdoctoral fellowship award for Alexandre daSilva, American Heart Association01/2003 - 12/2005
Extramural, Endocannabinoids in Obesity, Merck & Co, Inc.01/2003 - 12/2004
Extramural, The Renin-Angiotensin-Aldosterone System and Obesity-induced Hypertension, Pharmacia Co.01/2002 - 12/2002
Extramural, Molecular Genetics Core Facility, Department of Health and Human Services01/2001 - 12/2002
Extramural, Jackson Heart Study, National Institutes of Health01/1999 - 12/2005
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health01/1998 - 12/2003
Extramural, Cardiorenal Adaptation in Obesity Hypertension - NRSA for Jeff Henegar, National Institutes of Health01/1998 - 12/2001
Extramural, Grant for Center for Excellence in Cardiovascular-Renal Research, Renal Care Foundation01/1998 - 12/2000
Extramural, Jackson Heart Study, Phase I Feasibility Study, National Institutes of Health01/1997 - 12/1999
Extramural, Grant for Center for Excellence in Cardiovascular-Renal Research, Renal Care Foundation01/1996 - 12/1997
Extramural, Role of Amylin in Mediating Cardiovascular Changes in Obesity, Amylin Pharmaceuticals01/1996 - 12/1996
Extramural, Neurohumoral Mechanisms of Obesity Hypertension - NRSA for Dion Zappe, National Institutes of Health01/1994 - 12/1996
Extramural, Obesity-Induced Hypertension: Role of the Sympathetic Nervous System & Renin-Angiotensin System - postdoctoral fellowship for Dion Zappe, American Heart Association, Mississippi Affiliate01/1994 - 12/1996
Extramural, The Renin-Angiotensin System and Obesity-Induced Hypertension, Bristol-Myers Squibb Co.01/1994 - 12/1996
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health01/1993 - 12/1999
Extramural, Physiology Graduate Fellowship Training Grant, GLAXO01/1993 - 12/1996
Extramural, Chronic Renal, Hormonal, and Blood Pressure Effects of a New Angiotensin Converting Enzyme Inhibitor During Chronic Congestive Heart Failure, Ciba-Geigy Corporation01/1990 - 12/1990
Extramural, Calcium Homeostasis in Hypertension, National Institutes of Health01/1989 - 12/1992
Extramural, Hormonal Control of Renal Function, National Institutes of Health01/1988 - 12/1994
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health01/1988 - 12/1993
Extramural, Chronic Renal Actions of Atrial Natriuretic Factor, National Institutes of Health01/1988 - 12/1991
Extramural, Role of Hyperinsulinemia in Obesity Hypertension, American Heart Association01/1988 - 12/1990
Extramural, Young Scholar Award, Marion Laboratories01/1988 - 12/1988
Extramural, Blood Pressure and Renal Function in Hyperinsulinemia, National Institutes of Health01/1987 - 12/1993
Extramural, Role of Hyperinsulinemia in Hypertension Associated with Obesity, National Institutes of Health01/1987 - 12/1987
Extramural, Comparison of the Chronic Renal and Blood Pressure Effects of a New Renin Inhibitor (CP-71362) With a Converting Enzyme Inhibitor in Conscious Dogs, Pfizer Central Research01/1986 - 12/1986
Extramural, Renal and Hormonal Mechanisms of Blood Pressure Control, National Institutes of Health01/1984 - 12/1987
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health01/1983 - 12/1988
Extramural, Neural Control of the Kidney, National Institutes of Health01/1983 - 12/1985
Extramural, Hormonal Control of Renal Function, National Institutes of Health01/1982 - 12/1987
Extramural, Angiotensin and Neural Control of Kidney, Mississippi Heart Association01/1982 - 12/1984
Extramural, Intrarenal Role of Renin Angiotensin System, Mississippi Heart Association01/1980 - 12/1982
Extramural, Hormonal Control of Renal Function, National Institutes of Health01/1978 - 12/1984
Extramural, Hormonal Control of Renal Function, National Institutes of Health01/1978 - 12/1982
Extramural, Intrarenal Role of the Renin-Angiotensin System, Mississippi Heart Association01/1978 - 12/1980
Extramural, Role of Adrenal Cortical Hormones in Regulating Renal Function, Kidney Foundation of Mississippi01/1978 - 12/1978
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health01/1977 - 12/1982
Extramural, Role of the Renal Medulla in the Control of Blood Pressure, Mississippi Heart Association01/1976 - 12/1977
Extramural, Peripheral Vascular Control During Hemorrhage, National Institutes of Health01/1975 - 12/1978

Publications

Biography

Hall JE Remembering Arthur C. Guyton, MD J Miss State Med Assoc, 150th Commemorative Edition 2018; 59: 526-531.2018
Hall JE, The renin-angiotensin-aldosterone system: a personal perspective and Festschrift for John H. Laragh, MD. American journal of hypertension, 2014 Aug;27(8):1005-72014
Hall JE, Cowley AW Jr, Bishop VS, Granger DN, Navar LG, Taylor AE, In memoriam. Arthur C. Guyton (1919-2003). The Physiologist, 2003 Jun;46(3):126-82003

Guideline

Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ, Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research, Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension (Dallas, Tex. : 1979), 2005 Jan;45(1):142-612005

Consensus Development Conference

Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV, Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation, 2012 Dec 11;126(24):2880-92012

Journal Article

Jones DW, Hall JE. Racial and ethnic differences in blood pressure: biology and sociology Circulation. 2006; 114:2757-27592006
Liu J, daSilva AA, Tallam L, Hall JE. Chronic central nervous system hyperinsulinemia and regulation of arterial presure and food intake J Hypertension. 2006; 24:1391-13952006
daSilva AA, Tallam LS, Liu J, Hall JE. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity Am J Physiol Regul Integr Comp Physiol. 2006; 291:1275-12822006
Tallam LS, da Silva AA, Hall JE. The melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin Hypertension. 2006; 48:58-642006
Hall JE. Obesity, adipokines and hypertension J. Hypertension. 2006; 24 (Suppl. 6): 12-132006
daSilva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Does dietary-induced obesity induce “resistance” to the long-term cardiovascular and metabolic actions of hypothalamic melanocortin 3/4 receptor activation? Hypertension. 2006; 47:259-2642005
Tallam LS, Stec DE, Willis MA, daSilva AA, Hall JE. Melanocortin-4 receptor deficient mice are not hypertensive or salt-sensitive despite obesity, insulin resistance and hypertleptinemia Hypertension. 2005; 46:326-3322005
Vachharajani VT, Russsell JM, Scott KL, Conrad S, Stokes KY, Tallam L, Hall JE, Granger DN. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain Microcirculation. 2005; 12:183-1942005
Gu JW, Fortepiani L, Reckelhoff JF, Adair TH, Wang J, Hall JE. Increased vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats Microcirculation. 2004; 11:689-6972004
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz TW, Sheps SG, Roccella EJ. Recommendations for measuring blood pressure in humans and animals. Part 1. Blood pressure measurement in humans Hypertension. 2005; 45:142-1612004
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for measuring blood pressure in humans and animals. Part 2. Blood pressure measurement in animals Hypertension. 2005; 45:299-3102004
Tallam LS, Kuo JJ, daSilva AA, Hall JE. Cardiovascular, renal and metabolic responses to chronic central administration of agouti related peptide Hypertension. 2004; 44:853-8582004
Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension Curr Pharm Des. 2004; 10:3621-36372004
Gu JW, Wang J, Stockton A, Lokitz B, Henegar L, Hall JE. Cytokine gene expression profiles in kidney medulla and cortex of obese hypertensive dogs Kidney Int. 2004; 66:713-7212004
Philip-Couderc P, Smih F, Hall JE, Patul A, Roncalli J, Massabuau P, Galinier M, Senard JM, Rouet P Kinetic analysis of cardiac transcriptome regulation during chronic high fat diet in dogs Physiol Genomics. 2004; 19:32-402004
Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol. 2004; 286:R803-R8132004
da Silva AA, Kuo JJ, Hall JE. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal and metabolic actions of leptin Hypertension. 2004; 43:1312-13172004
Salahudeen AK, Fleischmann EH, Bower JD, Hall JE. Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population Nephrol Dial Transplant. 2004; 19:427-4322004
Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, Tallam L. Is obesity a major cause of chronic renal disease? Adv Ren Replacement Ther. 2004; 11:41-542004
Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation Hypertension. 2004; 43:370-3752004
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension Hypertension. 2004; 43:383-3872004
DePaula RB, daSilva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration Hypertension. 2004; 43:41-472003
Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam L, Liu J. Impact of the obesity epidemic on hypertension and kidney disease Curr Hypertens Rep. 2003; 5:386-3922003
Hall JE. Historical perspective of the renin-angiotensin system Mol Biotechnol. 2003; 24:27-392003
Kuo JJ, Jones OB, Hall JE. Chronic cardiovascular and renal actions of leptin during hyperinsulinemia Am J Physiol. 2003; 284:R1037-R10422003
Hall JE, Kuo JJ, da Silva A, DePaula R, Liu J, Tallam L. Obesity-associated hypertension and kidney disease Curr Opin Nephrol Hypertens. 2003; 12:195-2002003
Hall JE. The kidney, obesity, and hypertension Hypertension. 2003; 41:625-6332003
Kuo JJ, Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function Hypertension. 2003; 41:768-7742002
Hall JE, Crook ED, Dubbert PM, Jones DW, Wofford MR. Mechanisms of obesity-associated cardiovascular and renal disease Am J Med Sci. 2002; 324:127-1372002
Dubbert PM, Carithers T, Sumner AE, Barbour K, Clark B, Hall JE, Crook ED. Obesity, physical inactivity, and risk for cardiovascular disease Am J Med Sci. 2002; 324:116-1262002
Crook ED, Flack JM, Salem M, Salahudeen AK, Hall JE. Primary renal disease as a cardiovascular risk factor Am J Med Sci. 2002; 324:138-1452002
Hall JE, Jones DW What can we do about the "epidemic" of obesity? Am J Hypertens. 2002; 15:657-6592002
Carlyle ME, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity Hypertension. 2002; 39:496-5012002
Fitzgerald SM, Hall JE, Brands MW. Rapid hypotensive response to fasting in
spontaneously hypertensive rats
Am J Hypertension. 2001; 14:1123-1127
2001
Hall JE. The promise of translational physiology Am J Physiol. 2001; 281:C1411-C14122001
Fitzgerald SM, Henegar JR, Brands MW, Henegar LK, Hall JE. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats Am J Physiol. 2001; 281:R547-R5522001
Wofford, MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of α and β blockade in obese and lean hypertensive subjects Am J Hypertens. 2001; 14:694-6982001
Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity J Am Soc Nephrol. 2001; 12:1211-12172001
Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension – role of leptin and sympathetic nervous system Am J Hypertens. 2001; 14:103s-115s2001
Kuo J, Jones OB, Hall JE. Inhibition of NO enhances the cardiovascular and renal actions of leptin Hypertension. 2001; 37:670-6762001
Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Bigler SA, Hall JE. Distribution of renal medullary hyaluronan in lean and obese rabbits Kidney Int. 2000; 58:721-7292000
Dwyer TM, Bigler SA, Moore NA, Carroll JF, Hall JE. The altered structure of renal papillary outflow tracts in obesity Ultrastruct Pathol. 2000; 24:251-2572000
Hall JE, Brands MW, Hildebrandt DA, Kuo J, Fitzgerald S. Role of the sympathetic nervous system and neuropeptides in obesity hypertension Braz J Med Biol Res. 2000; 33:605-6182000
Hall JE. Pathophysiology of obesity hypertension Curr Hypertens Rep. 2000; 2:139-1472000
Hall JE. Integration and regulation of cardiovascular function Am J Physiol. 1999; 22:s174-s1861999
Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity Ann N Y Acad Sci. 1999; 892:91-1071999
Khalil RA, Crews JK, Carroll JF, Hall JE. Enhanced vascular reactivity and Ca2+ entry with low salt diet. Effect of obesity Hypertension. 1999; 34:882-8881999
Hall JE, Shek EW, Brands MW. Does leptin contribute to obesity hypertension? Curr Opin Endocrinol Diab. 1999; 6:225-2291999
Hall JE. Angiotensin II and long-term arterial pressure regualation: the overriding dominance of the kidney J Am Soc Nephrol. 1999; 10 (Suppl 12):s258-s2651999
Hildebrandt DA, Smith MJ Jr., Hall JE. Cardiovascular regulation during insulin infusion into the carotid or vertebral artery in dogs J Hypertens. 1999; 17:251-2601999
Hall JE. Renal mechanisms of obesity hypertension and relevance to essential hypertension Therapeutic Research. 1999; 20:78-911999
Brands MW, Hall JE. Renal perfusion pressure is an important determinant of sodium and calcium excretion in DOC-salt hypertension Am J Hypertens. 1998; 11:1199-12071998
Keen HL, Brands MW, Smith Jr. MJ, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats Hypertension. 1998; 31:637-6421998
Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure Hypertension. 1998; 31:409-4141998
Hall JE. Sodium and hypertension: Physiology Proc Nat Kid Found., Clin Nephrol. 1998; 105-1061998
Hall JE, Brands MW, Henegar JR, Skek EW-M Abnormal kidney function as a cause and a consequence of obesity hypertension Clin Exp Pharmacol Physiol. 1998; 25:65-691998
Brands MW, Hall JE, Keen HL Is insulin resistance linked to hypertension? Clin Exp Pharmacol Physiol. 1998; 25:70-761998
Keen HL, Brands MW, Smith MJ Jr., Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats Am J Hypertens. 1997; 10:1125-11311997
Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension Am J Hypertens. 1997; 10:49s-55s1997
Rust OA, Bofill JA, Magann EF, Zappe DH, Hall JE, Burnett JC, Martin JA. The origin of endothelin in patients with severe peeeclampsia Obstet Gynecol. 1997; 89:754-7571997
Summers RL, Montani JP, Woodward LH, Coleman TG, Hall JE. Theoretical analysis of the mechanisms of hyperinsulinemia Comput Biol Med. 1997; 27:249-2561997
Hall WD, Ferrario CM, Moore MA, Hall JE, Flack JM, Cooper W, Simmons JD, Egan BM, Lackland DT, Perry M Jr, Roccella EJ. Hypertension related morbidity and mortality in the Southeastern United States Am J Med Sci. 1997; 313:195-2091997
Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system Hypertension. 1997; 29:1014-10191997
Keen HL, Brands MW, Smith MJ Jr, Shek EW, Hall JE. Thromboxane is required for full expression of angiotensin hypertension in rats Hypertension. 1997; 29:310-3141997
Keen H L, Brands MW, Alonso-Galacia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats Am J Hypertens. 1996; 9:1192-11991996
Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats: Role of angiotensin II and adrenergic activity Hypertension. 1996; 28:1047-10541996
Hall JE, Zappe DH, Alonso-Galicia M, Granger JP, Brands MW, Kassab SE. Mechanisms of obesity-induced hypertension News Physiol Sci. 1996; 11:255-2611996
Hall JE, Brands MW, Shek E. Central role of the kidneys and abnormal fluid volume control in hypertension J Hum Hypertens. 1996; 10:633-6391996
Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats Am J Physiol. 1996; 271:R276-R2811996
Summers RL, Woodward LH, Sanders DY, Hall JE. Graphical analysis for the study of metabolic states Advan Physiol Educ. 1996; 270:s81-s871996
Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Cardiovascular actions of insulin: Are they important in long-term blood pressure regulation? Clin Exp Pharmacol. 1995; 22:689-7001995
Van Vliet BN, Hall JE, Mizelle LH, Montani JP, Smith Jr. MJ. Reduced parasympathetic control of heart rate in obese dogs Am J Physiol. 1995; 269:H629-H6371995
Hall JE, Brands MW, Zappe DH, Granger JP, Kassab S, Alonso-Galicia M , Keen H. Pathophysiology of obesity associated hypertension J Hypertension. 1995; 2 (Suppl 2): s3-s131995
Brands MW, Hall JE, Van Vliet BN, Alonso-Galicia M., Herrera GA, Zappe DH. Obesity and hypertension: Roles of hyperinsulinemia, sympathetic nervous system, and intrarenal mechanisms J Nutr. 1995; 125:1725s-1731s1995
Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart, Hildebrandt DA. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin resistant dogs Hypertension. 1995; 25:994-10021995
Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner medulla of obese dogs Hypertension. 1995; 25:888-8921995
Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Insulin resistance, hyperinsulinemia and hypertension: Causes, consequences, or merely correlations? Proc Soc Exp Biol Med. 1995; 208:317-3291995
Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity Hypertension. 1995; 25:893-8971995
Hall JE, Summers RL, Keen H, Brands MW, Alonso-Galicia M. Insulin resistance and its role in hypertension Am J Hypertens. 1994; 7:772-7881994
Hall JE. Louis K. Dahl memorial lecture. Renal and cardiovascular mechanisms of hypertension in obesity Hypertension. 1994; 23:381-3941994
Hall JE, Brands MW, Zappe DH, Keen H, Alonso-Galicia M. The insulin hypothesis of hypertension-experimental evidence J Hypertens. 1994; Ed. Esp 1 (Suppl. 1): S3-S131994
Brands MW, Garrity CA, Holman MG, Hall JE. Exaggerated pressor and chronotropic responses to chronic hyperinsulinemia in SH and WKY rats Am J Hypertens. 1994; 7:75-811994
Brands MW, Garrity CA, Holman MG, Hall JE. High fructose diet does not raise 24 hour mean arterial pressure in rats Am J Hypertens. 1994; 7:104-1091994
Hall JE, Brands MW, Dixon WN, Smith Jr. MJ. Obesity-induced hypertension: Renal function and systemic hemodynamics Hypertension. 1993; 22:292-2991993
Mizelle HL, Montani JP, Hester RL, Didlake RH, Hall JE. Role of pressure natriuresis in long-term control of renal electrolyte excretion Hypertension. 1993; 22:102-1101993
Hall JE. Hyperinsulinemia: A link between obesity and hypertension? Kidney Int. 1993; 43:1402-14171993
Brands MW, Alonso- Galicia M, Mizelle HL, Hildebrandt DA, Hall JE. Chronic angiotensin converting enzyme inhibition improves cardiac output and fluid balance during heart failure Am J Physiol. 1993; 264:R414-R4221993
Brands MW, Hall JE. Insulin resistance, hyperinsulinemia, and obesity- associated hypertension J Am Soc Nephrol. 1992; 3:1064-10771992
Hildebrandt DA, Mizelle HL, Brands MW, and Hall JE. Comparison of renal actions of urodilation and atrial natriuretic peptide Am J Physiol. 1992; 262:R395-R3991992
Hall JE. Kidney function and hypertension Japan J Appl Physiol. 1992; 22(Suppl.):59-601992
Hall JE, Brands MW. Obesity-associated hypertension: Role of insulin and renal mechanisms Spectrum der Nephrologie. 1992;8: 3-121992
Brands, MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive Hypertension. 1992; 19 (Suppl. I): I83-I891992
Mizelle HL, Gaillard CA, Manning RD, Hall JE. Mechanism of decreased cardiac output during ANP infusion in conscious anephric dogs Am J Physiol. 1992; 262:R120-R1251992
Hall JE, Brands MW, Hildebrandt DA, Mizelle HL. Obesity-associated hypertension: Hyperinsulinemia and renal mechanisms Hypertension. 1992; 19 (Suppl I):I45-I551992
Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Pressure natriuresis and angiotensin II in reduced kidney mass- salt induced hypertension Am J Physiol. 1992; 262:R61-R711992
Hall JE. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension Am J Hypertens. 1991; 4 (10 Pt 2):523s-533s1991
Hall JE. Control of blood pressure by the renin-angiotensin-aldosterone system Clin Cardiol. 1991; 14 (Suppl. 4): 6-211991
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia does not cause hypertension Am J Physiol. 1991; 260:F663-F6691991
Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats Am J Physiol. 1991; 260:R764-R7681991
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs Am J Hyper. 1991; 4:164-1681991
Gaillard CA, Mizelle HL, Montani JP, Brands MW, Hildebrandt DA, Hall JE. Atrial natriuretic factor and blood pressure control: Role of sodium and aldosterone Am J Physiol. 1990; 259:R973-R9801990
Hildebrandt DA, Mizelle HL, Brands MW, Gaillard CA, Smith Jr. MJ, Hall JE. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically Am J Physiol. 1990; 259:R585-R5921990
Hildebrandt DA, Mizelle HL, Brands MW, Gaillard CA, Smith MJ Jr, Hall JE. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically Am J Physiol. 1990; 259:R585-R5921990
Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis: A cause or a consequence of hypertension? Hypertension. 1990; 15:547-5591990
Mizelle HL, Hildebrandt DA, Gaillard CA, Brands MW, Montani JP, Smith Jr. MJ, Hall JE. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs Am J Physiol. 1990; 258:R1445-R14521990
Hall JE, Brands MW, Mizelle HL, Kivlighn SD, Hildebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure: Interactions with catecholamines? Hypertension. 1990; 15:519-5271990
Hall JE, Mizelle HL. Control of arterial pressure and renal function during chronic renin inhibition J Hypertens. 1990; 8:352-3601990
Hall JE, Coleman TG, Mizelle HL, Smith Jr. MJ. Chronic hyperinsulinemia and blood pressure regulation Am J Physiol. 1990; 258:F722-F7311990
Hall JE, Guyton AC, Mizelle HL. Role of the renin-angiotensin system in control of sodium excretion and arterial pressure Acta Physiologica-Scandinavia. 1990; 139 (Suppl. 591): 48-621990
Mizelle HL, Hall JE, Hildebrandt DA. Atrial natriuretic peptide and pressure natriuresis: Interactions with angiotensin Am J Physiol. 1989; 257:R1169-R11741989
Hall JE. Intrarenal actions of converting enzyme inhibitors Am J Hypertens. 1989; 2:875-8841989
Hall JE, Coleman TG, Guyton AC. The renin-angiotensin system: Normal physiology and changes in older hypertensives J Am Geriatr Soc. 1989; 37: 801-8131989
Mizelle HL, Hall JE, Montani JP. Role of renal nerves in control of sodium excretion during chronic congestive heart failure Am J Physiol. 1989; 256:F1084-F10931989
Hall JE, Coleman TG, Mizelle HL. Does Chronic Hyperinsulinemia Cause Hypertension? Am J Hyper. 1989; 2:171-1731989
Woods LL, Mizelle HL, Hall JE. Control of sodium excretion in NE-ACTH hypertension: Role of pressure natriuresis Am J Physiol. 1988; 255:R894-R9001988
Mizelle HL, Hall JE, Woods LL. Interactions between angiotensin II and the renal nerves during chronic sodium deprivation Am J Physiol. 1988; 255:F823-F8271988
Hall JE, Mizelle HL, Montani JP, Woods LL. Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion J Hypertens. 1988; 6:723-7321988
Guyton AC, Montani JP, Hall JE, Manning Jr. RD. Computer models for designing hypertension experiments and studying concepts Am J Med Sci. 1988; 295:320-3261988
Guyton AC, Hall JE, Montani JP. Kidney function and hypertension Acta Physiologica Scandinavica. 1988; 133 (Suppl. 571): 163-1731988
Woods LL, Mizelle HL, Hall JE. Role of the liver in renal hemodynamic response to amino acid infusion Am J Physiol. 1987; 252:F981-F9851987
Olsen ME, Hall JE, Montani JP, Cornell JE. Interaction with renal prostaglandins and angiotensin II in controlling glomerular filtration in the dog Clin Sci. 1987; 72:429-4361987
Mizelle HL, Hall JE, Woods LL, Montani JP. Role of renal nerves in compensatory adaptation to chronic reductions in sodium intake Am J Physiol. 1987; 252:F291-F2981987
Woods LL, Mizelle HL, Hall, JE. Autoregulation of renal blood flow and glomerular filtration rate in the pregnant rabbit Am J Physiol. 1987; 252:F69-F721987
Woods LL, Mizelle Hl, Hall JE. Control of renal hemodynamics in hyperglycemia: Possible role of tubuloglomerular feedback Am J Physiol. 1987; 252:F65-F731987
Hall JE, Guyton AC, Coleman TG, Mizelle HL, Woods LL. Regulation of arterial pressure: Role of pressure natriuresis and diuresis Fed Proc. 1986; 45: 2897-29031986
Guyton AC, Manning Jr. RD, Norman Jr. RA, Montani JP, Lohmeier TE, Hall JE. Current concepts and perspectives of renal volume regulation in relationship to hypertension J Hypertens. 1986; 4(Suppl. 4):S49-S561986
Hall JE, Granger JP, Hester RL, Montani JP. Mechanisms of sodium balance in hypertension: Role of pressure natriuresis J Hypertens. 1986; 4(Suppl. 4):S57-S651986
Woods LL, Mizelle HL, Montani JP, Hall JE. Mechanisms controlling renal hemodynamics and electrolyte excretion during amino acids Am J Physiol. 1986; 251:F303-F3121986
Hall JE, Mizelle HL, Woods LL. The renin-angiotensin system and long-term regulation of arterial pressure J Hypertens. 1986; 4:387-3971986
Hall JE. Control of sodium excretion by angiotensin: Intrarenal mechanisms and blood pressure regulation Am J Physiol. 1986; 250:R960-R9721986
Hall JE, Granger, JP. Adenosine alters glomerular filtration control by angiotensin II Am J Physiol. 1986; 250:F917-F9231986
Hall JE, Montani JP, Woods LL, Mizelle HL. Renal escape from vasopressin: Role of pressure diuresis Am J Physiol. 1986; 250: F907-F9161986
Hall JE. Regulation of glomerular filtration and sodium excretion by angiotensin II Fed Proc. 1986; 45:1431-14371986
Hall JE, Granger JP. Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs Am J Physiol. 1986; 250:F32-F391986
Olsen ME, Hall JE, Montani JP, Cornell JE. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins J Hypertens. 1985; 3(Suppl 3):S255-S2581985
Olsen ME, Hall JE, Montani JP, Guyton AC, Langford HG, Cornell JE. Mechanisms of angiotensin II natriuresis and antinatriuresis Am J Physiol. 1985; 249:F299-F3071985
Premen AJ, Hall JE, Smith Jr. MJ. Postprandial regulation of renal hemodynamics: Role of pancreatic glucagon Am J Physiol. 1985; 248:F656-F6621985
Hall JE, Granger JP, Hester RL. Interactions between adenosine and angiotensin II in controlling glomerular filtration Am J Physiol. 1985; 248:F340-F3471985
Premen AJ, Hall JE, Mizelle LH, Cornell JE. Maintenance of renal autoregulation during infusion of aminophylline or adenosine Am J Physiol. 1985; 248:F366-F3731985
Granger JP, Hall JE. Control of renal hemodynamics, electrolyte excretion, and arterial pressure during acute and chronic intrarenal infusion of bradykinin Am J Physiol. 1985; 248:F87-R921985
Guyton AC, Coleman TG, Manning Jr RD, Hall JE. Some problems and solutions for modeling overall cardiovascular regulation Math Biosci. 1984; 72:141-1551984
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and antinatriuresis: Role of renal artery pressure in anesthetized dogs J Hypertens. 1984; (Suppl 3):347-3501984
Kastner PK, Hall JE, Guyton AC. Control of glomerular filtration rate: Role of intrarenally formed Angiotensin II Am J Physiol. 1984; 246: F897-F9061984
Hall JE, Granger JP, Hester RL, Coleman TG, Smith Jr MJ, Cross RB. Mechanisms of escape from sodium retention during angiotensin II hypertension Am J Physiol. 1984; 246:F627-F6341984
Hall JE, Granger JP, Smith Jr MJ, Premen AJ. Role of renal hemodynamics and arterial pressure in aldosterone "escape" Hypertension. 1984; 6(Suppl. 1) I183-I1921984
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and antinatriuresis-Role of renal artery pressure, renal hemodynamics, and tubular reabsorption Acta Medica Scandinavica. 1984; S693:81-881984
Guyton AC, Manning Jr RD, Hall JE, Young DB. Renal abnormalities that cause hypertension versus those that cause uremia Neth J Med. 1984; 27:117-1231984
Guyton AC, Manning Jr RD, Hall JE, Norman Jr RA, Young DB, Pan YJ. The pathogenic role of the kidney J Cardiovasc Pharmacol. 1984; 6 (Suppl. 1): S151-S1611984
Hall JE, Granger JP. Renal hemodynamic actions of angiotensin II: Interactions with tubuloglomerular feedback Am J Physiol. 1983; 245:R166-R1731983
Hester RL, Granger JP, Williams J, Hall JE. Acute and chronic servo-control of renal perfusion pressure Am J Physiol. 1983; 244:F455-F4601983
Navar LG, Marsh DJ, Blantz RC, Hall JE, Ploth DW, Nasjletti A. Intrinsic control of renal hemodynamics Fed Proc. 1982; 41:3022-30301982
Kastner PK, Hall JE, Guyton AC. Renal hemodynamic responses to increased renal venous pressure: Role of angiotensin II Am J Physiol. 1982; 243:F260-F2641982
Hall JE, Granger JP. Mechanisms of the blood pressure and renal hemodynamic effects of captopril Am J Cardiol. 1982; 49:1527-15291982
Hall JE, Coleman TG, Guyton AC, Kastner PR, Granger JP. Control of glomerular filtration by circulating angiotensin II Am J Physiol. 1981; 241:R190-R1971981
Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Kastner PR. Blood pressure regulation: Basic concepts Fed Proc. 1981; 40: 2252-22561981
Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Manning Jr RD. The Ninth J. A. F. Stevenson Memorial Lecture: The many roles of the kidney in arterial pressure control and hypertension Can J Physiol Pharmacol. 1981; 59: 513-5191981
Hall JE, Guyton AC, Jackson TE, Kastner PR, Granger JP. Autoregulation of glomerular filtration role of angiotensin Proceedings from the Eighth International Congress of Nephrology. Symposium on Renal Hemodynamics. 1981; pp 162-1691981
Hall JE, Guyton AC, Smith Jr. MJ, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin Am J Physiol. 1980; 239:F271-F2801980
Hall JE, Morse CL, Smith Jr. MJ, Young DB, Guyton AC. Control of arterial pressure and renal function during glucocorticoid excess in dogs Hypertension. 1980; 2:39-1481980
Guyton AC, Hall JE, Young DB, Lohmeier TE, Jackson TE, Kastner PR. A computer and experimental analysis of arterial pressure regulation and hypertension Cardiovasc Physiol. 1980; 8:13-271980
Salgado HC, Hall JE, Guyton AC. Effects of acute rehydration on renin release in conscious dogs Acta Physiologica Latino Americana. 1980; 30:73-741980
Hall JE, Guyton AC, Smith JR MJ, Coleman TG. Long-term regulation of arterial pressure, glomerular filtration, and renal sodium reabsorption by angiotensin II Clin Sci. 1980; 59(Suppl. 6): 87s-90s1980
Young DB, Lohmeier TE, Hall JE, DeClue JE, Bengis RG, Coleman TG, Guyton AC. The role of the renal effects of angiotensin II in hypertension Cor Vasa. 1980; 22:49-581980
Hall JE, Guyton AC, Smith JR MJ, Coleman TG. Chronic blockade of angiotensin II formation during sodium deprivation Am J Physiol. 1979; 237:F424-4321979
Hall JE, Coleman TG, Guyton AC, Balfe JW, Salgado HC. Intrarenal role of angiotensin II and [Des-Asp1] angiotensin II Am J Physiol. 1979; 236:F252-2591979
Guyton AC, Hall JE. The juxtaglomerular complex: Its possible control of multiple nephron functions Nature. 1979; 277:601-6021979
Hall JE, Guyton AC, Salgado HC, McCaa RE, Balfe JW. Renal hemodynamics in acute and chronic angiotensin II hypertension Am J Physiol. 1978; 235:F174-F1791978
Guyton AC, Cowley Jr AW, Coleman TG, McCaa RE, Young DB, Hall JE. Physiological basis of blood pressure control Tribuna Medica. 1978; 38:3-111978
Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by renin-angiotensin system Am J Physiol. 1977; 233:F366-F3721977
Lohmeier TE, Cowley Jr AW, Trippodo NC, Hall JE, Guyton AC. Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics Am J Physiol. 1977; 233:F388-3991977
Jackson TE, Guyton AC, Hall JE. Transient responses of glomerular filtration rate and renal blood flow to step changes in arterial pressure Am J Physiol. 1977; 233:F396-F4021977
Hall JE, Guyton AC, Trippodo NC, Lohmeier TE, McCaa RE, Cowley Jr AW. Intrarenal control of electrolyte excretion by angiotensin II Am J Physiol. 1977; 233:F538-F5441977
Trippodo NC, Hall JE, Lohmeier TE, Guyton AC. Intrarenal role of angiotensin II in controlling sodium excretion in dehydrated dogs Clin Sci Mol Med. 1977; 52:545-5481977
Hall JE, Guyton AC, Cowley Jr. AW. Dissociation of renal blood flow and filtration rate autoregulation by renin depletion Am J Physiol. 1977; 232:F215-F2211977
Guyton AC, Hall JE, Young DB, DeClue JW, Lohmeier TE, McCaa RE. Role of the kidney in the control of blood pressure Medicina. 1977; 37(SI):30-391977
Guyton AC, Cowley Jr. AW, Young DB, Hall JE, Lohmeier TE. The hemodynamics of hypertension Excerpta Medica. 1977; 5-211977
Hall JE, Guyton AC, Farr BM. A single injection method for measuring glomerular filtration rate Am J Physiol. 1977; 232:F72-F761977
Hall JE, Guyton AC. Changes in renal hemodynamics and renin release caused by increased plasma oncotic pressure Am J Physiol. 1976; 231:1550-15561976
Guyton AC, Coleman TG, Norman Jr. RA, Hall JE, Young DB. Overall circulatory control in hypertension Aust N Z J Med (Supplement 2). 1976;6:72-801976
Hall JE, Schwinghamer JM, Lalone B. Mechanisms of blood vessel constriction during hemorrhage Am J Physiol. 1976; 230:569-5781976
Guyton AC, Young DB, DeClue JW, Trippodo N, Hall JE. Fluid balance, renal function, and blood pressure Clin Nephrol. 1975; 4:122-1261975
Hall JE. Hypertension Update 2011 Hypertension. 2011; 58:975-9772011
Hall JE. Hypertension Update 2008 Hypertension. 2008; 52:425-4282008
Brandon EL. Cantwell L. Gu JW, Hall JE. Obesity enhances melanoma tumor growth independently of leptin FASEB J. 2007; 21:A9272007
Jones DW, Hall JE. World Hypertension Day 2007 Hypertension. 2007; 49:939-9402007
Hall JE. Hypertension Update 2006 Hypertension. 2006; 48:343-3462006
Hall JE. Hypertension update -2005 Hypertension. 2005; 45:316-3182005
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee Arterioscler Thromb Vasc Biol. 2005; 25:478-4792005
Hall JE. The pioneering use of systems analysis to study cardiac output regulation Am J Physiol. 2004; 287:R1009-R10112004
Benos DJ, Kirk KL, Hall JE. How to review a paper Adv Physiol Educ. 2003; 27:47-522003
Hall JE, Cowley AW Jr, Bishop VS, Granger DN, Navar LG, Taylor AE. In memoriam. Arthur C. Guyton (1919-2003) The Physiologist. 2003; 46:126-1282003
Loscalzo J, Balaban R , Becker LB, Ginsburg GS, Hachinski VC, Hall JE, Heisted DD, Leinwald LA, Lenfant CJ, Marban E, Olson EN, Schwartz SM Task force on strategic research direction-basic science subgroup key topics report Circulation. 2002; 106:e149-e1612002
Jones DW, Hall JE. The National High Blood Pressure Education Program: Thirty years and counting Hypertension. 2002; 39:941-9422002
Hall JE. Hypertension – an update Hypertension. 2002; 40:115-1162002
Hall JE. Hypertension – opportunities and challenges Hypertension. 2002; 39:1-22002
Hall JE. The postgenomic era – a golden age for physiologists? The Physiologist. 2001; 44:65, 74-792001
Hall JE. Pathophysiology of cardiorenal systems in obesity: a symposium in memory of A. Clifford Barger Clin Exper Pharm Physiol. 1998; 25:571998
Juraschek SP, Miller ER 3rd, Chang AR, Anderson CAM, Hall JE, Appel LJ, Effects of Sodium Reduction on Energy, Metabolism, Weight, Thirst, and Urine Volume: Results From the DASH (Dietary Approaches to Stop Hypertension)-Sodium Trial. Hypertension (Dallas, Tex. : 1979), 2020 Mar;75(3):723-7292020
Yalamanchili C, Chittiboyina AG, Haider S, Vasquez Y, Khan S, do Carmo JM, da Silva AA, Pinkerton M, Hall JE, Walker LA, Khan IA, In search for potential antidiabetic compounds from natural sources: docking, synthesis and biological screening of small molecules from Lycium spp. (Goji). Heliyon, 2020 Jan;6(1):e027822020
do Carmo JM, da Silva AA, Gava FN, Moak SP, Dai X, Hall JE, Impact of leptin deficiency compared with neuronal-specific leptin receptor deletion on cardiometabolic regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2019 Oct 1;317(4):R552-R5622019
Gordon DM, Adeosun SO, Ngwudike SI, Anderson CD, Hall JE, Hinds TD Jr, Stec DE, CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation. Archives of biochemistry and biophysics, 2019 Sep 15;672:1080722019
da Silva AA, do Carmo JM, Wang Z, Hall JE, Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension. Current hypertension reports, 2019 Apr 26;21(6):462019
Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME, Obesity, kidney dysfunction and hypertension: mechanistic links. Nature reviews. Nephrology, 2019 Jun;15(6):367-3852019
Lohmeier TE, Hall JE, Device-Based Neuromodulation for Resistant Hypertension Therapy. Circulation research, 2019 Mar 29;124(7):1071-10932019
Wang Z, do Carmo JM, da Silva AA, Bailey KC, Aberdein N, Moak SP, Hall JE, Role of SOCS3 in POMC neurons in metabolic and cardiovascular regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2019 Apr 1;316(4):R338-R3512019
do Carmo JM, da Silva AA, Moak SP, da Silva FS, Spradley FT, Hall JE, Role of melanocortin 4 receptor in hypertension induced by chronic intermittent hypoxia. Acta physiologica (Oxford, England), 2019 Apr;225(4):e132222019
Edwards KS, Ashraf S, Lomax TM, Wiseman JM, Hall ME, Gava FN, Hall JE, Hosler JP, Harmancey R, Uncoupling protein 3 deficiency impairs myocardial fatty acid oxidation and contractile recovery following ischemia/reperfusion. Basic research in cardiology, 2018 Oct 29;113(6):472018
do Carmo JM, da Silva AA, Moak SP, Browning JR, Dai X, Hall JE, Increased sleep time and reduced energy expenditure contribute to obesity after ovariectomy and a high fat diet. Life sciences, 2018 Nov 1;212:119-1282018
Jones DW, Luft FC, Whelton PK, Alderman MH, Hall JE, Peterson ED, Califf RM, McCarron DA, Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment? Hypertension (Dallas, Tex. : 1979), 2018 Jul;72(1):10-112018
Adeosun SO, Gordon DM, Weeks MF, Moore KH, Hall JE, Hinds TD Jr, Stec DE, Loss of biliverdin reductase-A promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells. American journal of physiology. Renal physiology, 2018 Aug 1;315(2):F323-F3312018
do Carmo JM, da Silva AA, Freeman JN, Wang Z, Moak SP, Hankins MW, Drummond HA, Hall JE, Neuronal Suppressor of Cytokine Signaling 3: Role in Modulating Chronic Metabolic and Cardiovascular Effects of Leptin. Hypertension (Dallas, Tex. : 1979), 2018 Jun;71(6):1248-12572018
Kamimura D, Suzuki T, Wang W, deShazo M, Hall JE, Winniford MD, Kullo IJ, Mosley TH, Butler KR, Hall ME, Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Hypertension research : official journal of the Japanese Society of Hypertension, 2018 Aug;41(8):629-6382018
Hamza SM, Hall JE, Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice. Journal of visualized experiments : JoVE, 2018 Feb 14;(132)2018
da Silva AA, Freeman JN, Hall JE, do Carmo JM, Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice. American journal of physiology. Regulatory, integrative and comparative physiology, 2018 Apr 1;314(4):R533-R5392018
Aberdein N, Dambrino RJ, do Carmo JM, Wang Z, Mitchell LE, Drummond HA, Hall JE, Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance. American journal of physiology. Regulatory, integrative and comparative physiology, 2018 Mar 1;314(3):R478-R4882018
Hart EC, Head GA, Carter JR, Wallin BG, May CN, Hamza SM, Hall JE, Charkoudian N, Osborn JW, Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization. American journal of physiology. Heart and circulatory physiology, 2017 May 1;312(5):H1031-H10512017
do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, Perez de Lara CE, Hall JE, Role of the brain melanocortins in blood pressure regulation. Biochimica et biophysica acta. Molecular basis of disease, 2017 Oct;1863(10 Pt A):2508-25142017
do Carmo JM, da Silva AA, Romero DG, Hall JE, Changes in ambient temperature elicit divergent control of metabolic and cardiovascular actions by leptin. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017 Jun;31(6):2418-24282017
Muntner P, Abdalla M, Correa A, Griswold M, Hall JE, Jones DW, Mensah GA, Sims M, Shimbo D, Spruill TM, Tucker KL, Appel LJ, Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study). Hypertension (Dallas, Tex. : 1979), 2017 May;69(5):761-7692017
Wang Z, do Carmo JM, Aberdein N, Zhou X, Williams JM, da Silva AA, Hall JE, Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress. Hypertension (Dallas, Tex. : 1979), 2017 May;69(5):879-8912017
Hall ME, Halinski JA, Skelton TN, Campbell WF, McMullan MR, Long RC, Alexander MN, Pollard JD, Hall JE, Fox ER, Winniford MD, Kamimura D, Left Ventricular False Tendons are Associated With Left Ventricular Dilation and Impaired Systolic and Diastolic Function. The American journal of the medical sciences, 2017 Sep;354(3):278-2842017
Townsend EA, Naylor JE, Negus SS, Edwards SR, Qureshi HN, McLendon HW, McCurdy CR, Kapanda CN, do Carmo JM, da Silva FS, Hall JE, Sufka KJ, Freeman KB, Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats. Psychopharmacology, 2017 Sep;234(17):2597-26052017
Clemmer JS, Pruett WA, Coleman TG, Hall JE, Hester RL, Mechanisms of blood pressure salt sensitivity: new insights from mathematical modeling. American journal of physiology. Regulatory, integrative and comparative physiology, 2017 Apr 1;312(4):R451-R4662017
da Silva AA, Hall JE, Moak SP, Browning J, Houghton HJ, Micheloni GC, do Carmo JM, Role of autonomic nervous system in chronic CNS-mediated antidiabetic action of leptin. American journal of physiology. Endocrinology and metabolism, 2017 May 1;312(5):E420-E4282017
Bourgeois B, Watts K, Thomas DM, Carmichael O, Hu FB, Heo M, Hall JE, Heymsfield SB, Associations between height and blood pressure in the United States population. Medicine, 2017 Dec;96(50):e92332017
Yano Y, Butler KR, Hall ME, Schwartz GL, Knopman DS, Lirette ST, Jones DW, Wilson JG, Hall JE, Correa A, Turner ST, Mosley TH, Associations of Nocturnal Blood Pressure With Cognition by Self-Identified Race in Middle-Aged and Older Adults: The GENOA (Genetic Epidemiology Network of Arteriopathy) Study. Journal of the American Heart Association, 2017 Oct 27;6(11)2017
Hall ME, Wang W, Okhomina V, Agarwal M, Hall JE, Dreisbach AW, Juncos LA, Winniford MD, Payne TJ, Robertson RM, Bhatnagar A, Young BA, Cigarette Smoking and Chronic Kidney Disease in African Americans in the Jackson Heart Study. Journal of the American Heart Association, 2016 May 25;5(6)2016
Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, Hall JE, Hundley WG, Beta-Blocker Use Is Associated with Higher Renal Tissue Oxygenation in Hypertensive Patients Suspected of Renal Artery Stenosis. Cardiorenal medicine, 2016 Aug;6(4):261-82016
do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, de Lara Rodriguez CE, Hall JE, Obesity-Induced Hypertension: Brain Signaling Pathways. Current hypertension reports, 2016 Jul;18(7):582016
Hall JE, Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension. Circulation, 2016 Mar 1;133(9):894-9062016
do Carmo JM, da Silva AA, Wang Z, Freeman NJ, Alsheik AJ, Adi A, Hall JE, Regulation of Blood Pressure, Appetite, and Glucose by Leptin After Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons. Hypertension (Dallas, Tex. : 1979), 2016 Feb;67(2):378-862016
do Carmo JM, da Silva AA, Moak SP, Houghton HJ, Smith A, Hall JE, Regulation of Blood Pressure, Appetite, and Glucose by CNS Melanocortin System in Hyperandrogenemic Female SHR. American journal of hypertension, 2016 Jul;29(7):832-402016
Jones DW, Weatherly L, Hall JE, SPRINT: What Remains Unanswered and Where Do We Go From Here? Hypertension (Dallas, Tex. : 1979), 2016 Feb;67(2):261-22016
Bassi M, Nakamura NB, Furuya WI, Colombari DS, Menani JV, do Carmo JM, da Silva AA, Hall JE, Colombari E, Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function. Acta physiologica (Oxford, England), 2015 Apr;213(4):893-9012015
da Silva AA, do Carmo JM, Dubinion JH, Bassi M, Mokhtarpouriani K, Hamza SM, Hall JE, Chronic central nervous system MC3/4R blockade attenuates hypertension induced by nitric oxide synthase inhibition but not by angiotensin II infusion. Hypertension (Dallas, Tex. : 1979), 2015 Jan;65(1):171-72015
Chen M, Ma L, Hall JE, Liu X, Ying Z, Dual regulation of tumor necrosis factor-α on myosin light chain phosphorylation in vascular smooth muscle. American journal of physiology. Heart and circulatory physiology, 2015 Mar 1;308(5):H398-4062015
Henegar JR, Zhang Y, Hata C, Narciso I, Hall ME, Hall JE, Catheter-Based Radiofrequency Renal Denervation: Location Effects on Renal Norepinephrine. American journal of hypertension, 2015 Jul;28(7):909-142015
Bassi M, Furuya WI, Zoccal DB, Menani JV, Colombari E, Hall JE, da Silva AA, do Carmo JM, Colombari DS, Control of respiratory and cardiovascular functions by leptin. Life sciences, 2015 Mar 15;125:25-312015
do Carmo JM, da Silva AA, Hall JE, Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats. Journal of hypertension, 2015 Jun;33(6):1201-62015
Maranon R, Lima R, Spradley FT, do Carmo JM, Zhang H, Smith AD, Bui E, Thomas RL, Moulana M, Hall JE, Granger JP, Reckelhoff JF, Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2015 Apr 15;308(8):R708-132015
da Silva AA, Spradley FT, Granger JP, Hall JE, do Carmo JM, Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling. Journal of neurophysiology, 2015 Apr 1;113(7):2786-912015
Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME, Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circulation research, 2015 Mar 13;116(6):991-10062015
Munusamy S, do Carmo JM, Hosler JP, Hall JE, Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin. American journal of physiology. Renal physiology, 2015 Oct 15;309(8):F731-432015
do Carmo JM, da Silva AA, Sessums PO, Ebaady SH, Pace BR, Rushing JS, Davis MT, Hall JE, Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin. International journal of obesity (2005), 2014 Jun;38(6):775-832014
Maranon RO, Lima R, Mathbout M, do Carmo JM, Hall JE, Roman RJ, Reckelhoff JF, Postmenopausal hypertension: role of the sympathetic nervous system in an animal model. American journal of physiology. Regulatory, integrative and comparative physiology, 2014 Feb 15;306(4):R248-562014
Bassi M, Furuya WI, Menani JV, Colombari DS, do Carmo JM, da Silva AA, Hall JE, Moreira TS, Wenker IC, Mulkey DK, Colombari E, Leptin into the ventrolateral medulla facilitates chemorespiratory response in leptin-deficient (ob/ob) mice. Acta physiologica (Oxford, England), 2014 May;211(1):240-82014
Henegar JR, Zhang Y, De Rama R, Hata C, Hall ME, Hall JE, Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. American journal of hypertension, 2014 Oct;27(10):1285-922014
da Silva AA, do Carmo JM, Wang Z, Hall JE, The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology (Bethesda, Md.), 2014 May;29(3):196-2022014
Hall ME, Maready MW, Hall JE, Stec DE, Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation. American journal of physiology. Endocrinology and metabolism, 2014 Aug 1;307(3):E316-252014
do Carmo JM, da Silva AA, Ebaady SE, Sessums PO, Abraham RS, Elmquist JK, Lowell BB, Hall JE, Shp2 signaling in POMC neurons is important for leptin's actions on blood pressure, energy balance, and glucose regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2014 Dec 15;307(12):R1438-472014
da Silva AA, do Carmo JM, Hall JE, Role of leptin and central nervous system melanocortins in obesity hypertension. Current opinion in nephrology and hypertension, 2013 Mar;22(2):135-402013
Zouein FA, Zgheib C, Hamza S, Fuseler JW, Hall JE, Soljancic A, Lopez-Ruiz A, Kurdi M, Booz GW, Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertension research : official journal of the Japanese Society of Hypertension, 2013 Jun;36(6):496-5032013
Dubinion JH, do Carmo JM, Adi A, Hamza S, da Silva AA, Hall JE, Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension (Dallas, Tex. : 1979), 2013 May;61(5):1066-742013
Ying Z, do Carmo JM, Xiang L, da Silva AA, Chen M, Ryan MJ, Ostrowski M, Rajagopalan S, Hall JE, Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle. Circulation research, 2013 Aug 16;113(5):562-702013
do Carmo JM, da Silva AA, Rushing JS, Pace B, Hall JE, Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons. American journal of physiology. Regulatory, integrative and comparative physiology, 2013 Aug 15;305(4):R359-682013
do Carmo JM, da Silva AA, Dubinion J, Sessums PO, Ebaady SH, Wang Z, Hall JE, Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB life, 2013 Aug;65(8):692-82013
do Carmo JM, da Silva AA, Morgan J, Jim Wang YX, Munusamy S, Hall JE, Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in obese mice. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2012 Jul;22(7):598-6042012
do Carmo JM, da Silva AA, Rushing JS, Hall JE, Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2012 Mar 1;302(5):R561-72012
Fu Y, Hall JE, Lu D, Lin L, Manning RD Jr, Cheng L, Gomez-Sanchez CE, Juncos LA, Liu R, Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors. Hypertension (Dallas, Tex. : 1979), 2012 Mar;59(3):599-6062012
Bassi M, Giusti H, Leite CM, Anselmo-Franci JA, do Carmo JM, da Silva AA, Hall JE, Colombari E, Glass ML, Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight. Pflugers Archiv : European journal of physiology, 2012 Aug;464(2):145-532012
Bassi M, do Carmo JM, Hall JE, da Silva AA, Chronic effects of centrally administered adiponectin on appetite, metabolism and blood pressure regulation in normotensive and hypertensive rats. Peptides, 2012 Sep;37(1):1-52012
Hamza SM, Hall JE, Direct recording of renal sympathetic nerve activity in unrestrained, conscious mice. Hypertension (Dallas, Tex. : 1979), 2012 Sep;60(3):856-642012
Hall ME, Smith G, Hall JE, Stec DE, Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity. American journal of physiology. Regulatory, integrative and comparative physiology, 2012 Dec 15;303(12):R1241-502012
Hall JE, Granger JP, do Carmo JM, da Silva AA, Dubinion J, George E, Hamza S, Speed J, Hall ME, Hypertension: physiology and pathophysiology. Comprehensive Physiology, 2012 Oct;2(4):2393-4422012
Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV, The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation, 2011 Mar 15;123(10):1138-432011
do Carmo JM, Bassi M, da Silva AA, Hall JE, Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation. Hypertension (Dallas, Tex. : 1979), 2011 Mar;57(3):428-342011
Dubinion JH, da Silva AA, Hall JE, Chronic blood pressure and appetite responses to central leptin infusion in rats fed a high fat diet. Journal of hypertension, 2011 Apr;29(4):758-622011
do Carmo JM, da Silva AA, Cai Z, Lin S, Dubinion JH, Hall JE, Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension (Dallas, Tex. : 1979), 2011 May;57(5):918-262011
Kelsen S, Hall JE, Chade AR, Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease. American journal of physiology. Renal physiology, 2011 Jul;301(1):F218-252011
Hall ME, Smith G, Hall JE, Stec DE, Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. American journal of physiology. Heart and circulatory physiology, 2011 Jul;301(1):H253-602011
Fagard RH, Grassi G, Hall J, Harrap S, Lindholm LH, Schiffrin EL, Heagerty AM, International Society of Hypertension Low and Middle Income Countries Committee: Review of the goals of the Committee and of 5 years of ISH activities in low and middle income countries. Journal of hypertension, 2010 Mar;28(3):635-62010
Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G, Stec DE, Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. The Journal of biological chemistry, 2010 Jun 4;285(23):17271-62010
Dubinion JH, da Silva AA, Hall JE, Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. Journal of hypertension, 2010 Jul;28(7):1466-702010
da Silva AA, do Carmo J, Dubinion J, Hall JE, The role of the sympathetic nervous system in obesity-related hypertension. Current hypertension reports, 2009 Jun;11(3):206-112009
da Silva AA, do Carmo JM, Freeman JN, Tallam LS, Hall JE, A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes, 2009 Aug;58(8):1749-562009
do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, Hall JE, Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. American journal of physiology. Regulatory, integrative and comparative physiology, 2009 Sep;297(3):R803-122009
Brandon EL, Gu JW, Cantwell L, He Z, Wallace G, Hall JE, Obesity promotes melanoma tumor growth: role of leptin. Cancer biology & therapy, 2009 Oct;8(19):1871-92009
da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E, Hall JE, Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2008 Apr;51(4):884-902008
do Carmo JM, Hall JE, da Silva AA, Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. American journal of physiology. Heart and circulatory physiology, 2008 Nov;295(5):H1974-812008
Silva AA, Kuo JJ, Tallam LS, Liu J, Hall JE, Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation? Hypertension (Dallas, Tex. : 1979), 2006 Feb;47(2):259-642006
Tallam LS, da Silva AA, Hall JE, Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension (Dallas, Tex. : 1979), 2006 Jul;48(1):58-642006
da Silva AA, Tallam LS, Liu J, Hall JE, Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. American journal of physiology. Regulatory, integrative and comparative physiology, 2006 Nov;291(5):R1275-822006
Liu J, da Silva AA, Tallam LS, Hall JE, Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake. Journal of hypertension, 2006 Jul;24(7):1391-52006
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE, Subcommittee of Professional and Public Education of the American Heart Association, Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension (Dallas, Tex. : 1979), 2005 Feb;45(2):299-3102005
Vachharajani V, Russell JM, Scott KL, Conrad S, Stokes KY, Tallam L, Hall J, Granger DN, Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation (New York, N.Y. : 1994), 2005 Mar;12(2):183-942005
Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE, Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension (Dallas, Tex. : 1979), 2005 Aug;46(2):326-322005
de Paula RB, da Silva AA, Hall JE, Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension (Dallas, Tex. : 1979), 2004 Jan;43(1):41-72004
Kuo JJ, da Silva AA, Tallam LS, Hall JE, Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension (Dallas, Tex. : 1979), 2004 Feb;43(2):370-52004
da Silva AA, Kuo JJ, Tallam LS, Hall JE, Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension (Dallas, Tex. : 1979), 2004 Feb;43(2):383-72004
Hall JE, Henegar JR, Dwyer TM, Liu J, Da Silva AA, Kuo JJ, Tallam L, Is obesity a major cause of chronic kidney disease? Advances in renal replacement therapy, 2004 Jan;11(1):41-542004
Salahudeen AK, Fleischmann EH, Bower JD, Hall JE, Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004 Feb;19(2):427-322004
Davy KP, Hall JE, Obesity and hypertension: two epidemics or one? American journal of physiology. Regulatory, integrative and comparative physiology, 2004 May;286(5):R803-132004
da Silva AA, Kuo JJ, Hall JE, Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension (Dallas, Tex. : 1979), 2004 Jun;43(6):1312-72004
Philip-Couderc P, Smih F, Hall JE, Pathak A, Roncalli J, Harmancey R, Massabuau P, Galinier M, Verwaerde P, Senard JM, Rouet P, Kinetic analysis of cardiac transcriptome regulation during chronic high-fat diet in dogs. Physiological genomics, 2004 Sep 16;19(1):32-402004
Gu JW, Wang J, Stockton A, Lokitz B, Henegar L, Hall JE, Cytokine gene expression profiles in kidney medulla and cortex of obese hypertensive dogs. Kidney international, 2004 Aug;66(2):713-212004
Tallam LS, Kuo JJ, da Silva AA, Hall JE, Cardiovascular, renal, and metabolic responses to chronic central administration of agouti-related peptide. Hypertension (Dallas, Tex. : 1979), 2004 Dec;44(6):853-82004
Gu JW, Fortepiani LA, Reckelhoff JF, Adair TH, Wang J, Hall JE, Increased expression of vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats. Microcirculation (New York, N.Y. : 1994), 2004 Dec;11(8):689-972004
Kuo JJ, Jones OB, Hall JE, Chronic cardiovascular and renal actions of leptin during hyperinsulinemia. American journal of physiology. Regulatory, integrative and comparative physiology, 2003 Apr;284(4):R1037-422003
Kuo JJ, Silva AA, Hall JE, Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension (Dallas, Tex. : 1979), 2003 Mar;41(3 Pt 2):768-742003
Benos DJ, Kirk KL, Hall JE, How to review a paper. Advances in physiology education, 2003 Dec;27(1-4):47-522003
Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J, Impact of the obesity epidemic on hypertension and renal disease. Current hypertension reports, 2003 Oct;5(5):386-922003
Carlyle M, Jones OB, Kuo JJ, Hall JE, Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension (Dallas, Tex. : 1979), 2002 Feb;39(2 Pt 2):496-5012002
Dubbert PM, Carithers T, Sumner AE, Barbour KA, Clark BL, Hall JE, Crook ED, Obesity, physical inactivity, and risk for cardiovascular disease. The American journal of the medical sciences, 2002 Sep;324(3):116-262002
Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM, Mechanisms of obesity-associated cardiovascular and renal disease. The American journal of the medical sciences, 2002 Sep;324(3):127-372002
Crook ED, Flack JM, Salem M, Salahudeen AK, Hall J, Primary renal disease as a cardiovascular risk factor. The American journal of the medical sciences, 2002 Sep;324(3):138-452002
Loscalzo J, Balaban R, Becker LB, Ginsburg GS, Hachinski VC, Hall JE, Heistad DD, Leinwand LA, Lenfant CJ, Marban E, Olson EN, Schwartz SM, American Heart Association. Task Force on Strategic Research Direction. Basic Science Subgroup, Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. Circulation, 2002 Nov 12;106(20):e149-612002
McLaughlin PG, Drug therapy in asthma. Australian family physician, 1984 Mar;13(3):199-2031984
Chawla LS, Sehgal AK, Verma RS, Balakrishanan V, Chhuttani PN, Lundh test in the diagnosis of exocrine pancreatic insufficiency. The Indian journal of medical research, 1973 May;61(5):700-31973
Wofford MR, Hall JE, Pathophysiology and treatment of obesity hypertension. Current pharmaceutical design, 2004;10(29):3621-37
Maric C, Hall JE, Obesity, metabolic syndrome and diabetic nephropathy. Contributions to nephrology, 2011;170:28-35
Alpert JS, Chipkin SR, Aronin N, Diabetes mellitus and silent myocardial ischemia. Advances in cardiology, 1990;37:297-303
Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE, Obesity, hypertension, and chronic kidney disease. International journal of nephrology and renovascular disease, 2014;7:75-88
Chade AR, Hall JE, Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity. American journal of nephrology, 2016;44(5):354-367
Hall ME, Jordan JH, Juncos LA, Hundley WG, Hall JE, BOLD magnetic resonance imaging in nephrology. International journal of nephrology and renovascular disease, 2018;11:103-112
da Silva AA, Hall JE, do Carmo JM, Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions. PloS one, 2017;12(11):e0184805

Review Article

Hart EC, Head GA, Carter JR, Wallin BG, May CN, Hamza SM, Hall JE, Charkoudian N, Osborn JW Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization Am J Physiol: Heart and Circulatory Physiology. 2017; 312:H1031-H10512017
Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension Kidney Int. 1996; 49: S35-S411996
Hall JE. The renin-angiotensin system: Renal actions and blood pressure regulation Compr Ther. 1991; 17:8-171991

Abstracts

do Carmo JM, da Silva AA, Hall JE. AT1 receptor antagonism blockade but not mineralocorticoid receptor blockade lowers blood pressure in obese Zucker rats FASEB J. 2012; 26:1093.62012
Bassi M, Furuya WI, Nakamura NB, Columbari DS, Menani JV, Glass ML, Hall JE, Columbari E. Central mechanisms activated by leptin to modify hypercapnia-induced ventilatory responses FASEB J. 2012; 26:702.162012
Hamza SM, Hall JE. Direct recording of renal sympathetic nerve activity in unrestrained conscious mice FASEB J. 2012; 26:1091.462012
Zouein FA, Zgheib C, Hamza SM, Hall JE, Ruiz A, Juncos LA, Booz GA. Dual role of STAT3 in hypertension-induced cardiac remodeling FASEB J. 2012; 26:1060.192012
da Silva AA, do Carmo JM, Dubinion JH, Hall JE. Ganglionic blockade does not impair the chronic CNS-mediated antidiabetic action of leptin in streptozotocin-induced diabetic rats FASEB J. 2012; 26:1128.32012
Hamza SM, Dubinion JH, Adi A, Hall JE. Melanocortin 4 receptors in the paraventricular nucleus of the hypothalamus do not mediate the chronic metabolic or cardiovascular effects of leptin after established obesity in mice FASEB J. 2012; 26:876.132012
do Carmo JM, da Silva AA, Hall JE. Metabolic and appetite responses to fasting and refeeding in mice with Shp2 deletion in forebrain neurons FASEB J. 2012; 26:877.22012
Bassi M, do Carmo JM, Colombari R, Hall JE. Leptin treatment within RVLM/RTN regions enhances ventilatory response to CO2 in ob/ob mice Neuroscience. 2011; 62.A820.112011
do Carmo JM, da Silva AA, Hall JE. Differential control of appetite and cardiovascular function after selective rescue of melanocortin-4 receptor in proopiomelanocortin neurons Hypertension. 2011; 58:e92011
Bassi M, Nakamura N, Colombari D, Menani JV, Glass ML, Hall J, Colombari E. Effects of central injections of leptin or melanocortin antagonist on arterial pressure and ventilatory responses to hypercapnia Hypertension. 2011; 58:e1362011
Dubinion J, do Carmo J, Munusamy S, Hamza S, da Silva A, Hall JE. STAT3 inactivation in POMC neurons attenuates leptin-induced elevations in arterial pressure Hypertension. 2011; 58:e362011
Hamza SM, Hildebrandt DA, Hall JE. Acute mineralocorticoid receptor blockade produces rapid renal vasodilation with no impairment of autoregulation in vivo FASEB J. 2011; 25:lb6462011
do Carmo JM, da Silva AA, Rushing JS, Hall JE Cardiovascular and metabolic responses to chronic central MC3/4R antagonism in obese Zucker rats FASEB J. 2011; 25:823.62011
do Carmo JM, Bassi M, Hamza SM, da Sila AA, Hall JE. Cardiovascular and metabolic responses to thermoneutrality and cold ambient temperature in lean and obese leptin deficient mice FASEB J. 2011; 25:1028.42011
Dwyer TM, Stec DE, Hall JE, Csongradi E. Hyaluronan is required for the renal medulla to maximally concentrate urine FASEB J. 2011; 25:1079.52011
Fu Y, Hall JE, Lin L, Gomez-Sanchez C, Liu R. Aldosterone blunts tubuloglomerular feedback by activating mineralocorticoid receptors on the macula densa Hypertension. 2010; 56:e1582010
da Silva AA, Dubinion JH, do Carmo JM, Hall JE. Chronic central nervous system MC3/4R blockade attenuates the hypertension induced by peripheral nitric oxide synthase blockade but not by angiotensin II infusion Hypertension. 2010; 56:e1032010
do Carmo JM, Silva AA, Hall JE. Divergeny chronic metabolic and cardiovascular responses to leptin: effects of ambient temperature Hypertension. 2010; 56:e1052010
Munusamy S, do Carmo JM, Hosler JP, Hall JE. Role of mitochondrial dysfunction and ER stress in the development of obesity-induced renal injury Hypertension. 2010; 56:e622010
Smith GH, Hall ME, Stec DE, Hall JE. Cardiac-specific Cre-recombinase causes a dose-dependent transient reduction in systolic function FASEB J. 2010; 24:596.32010
Freeman JN, do Carmo JM, Hall JE, da Silva AA. Central NPY deficiency does not enhance the chronic actions of melanocortin 3 and 4 receptors (MC3/4R) activation on glucose homeostasis, appetite and cardiovascular function in diabetic mice FASEB J. 2010; 24:597.62010
do Carmo JM, Bassi M, da Silva AA, Hall JE. Chronic central nervous system MC3/4R activation exacerbates the cardiovascular responses to peripheral nitric oxide synthase inhibition FASEB J. 2010; 24:1051.12010
Bassi M, do Carmo JM, Silva AA, Hall JE. Chronic CNS actions of adiponectin on appetite, metabolism and blood pressure FASEB J. 2010; 24: 780.12010
do Carmo JM, Silva AA, Morgan J, Hall JE. Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in mice fed high fat-high fructose diet FASEB J. 2010; 24: 996.22010
Bassi M, do Carmo JM, Hamza S, Hall JE. Leptin deficiency impairs hypercapnic ventilatory responses independently of changes in body weight FASEB J. 2010; 24: 1026.42010
Freeman JN, doCarmo JM, Hall JE, daSilva AA. Central neuropeptide Y (NPY) deficiency does not enhance the dietary or cardiovascular responses to chronic activation of melanocortin 3 and 4 receptors (MC3/4R) Hypertension. 2009; 54:e1032009
doCarmo JM, Bassi M, daSilva AA, Hall JE. Control of cardiovascular, metabolic and respiratory functions during prolonged obesity in leptin-deficient and diet-induced obese mice Hypertension. 2009; 54:e1042009
doCarmo JM, daSilva AA, Hall JE. Divergent control of appetite, cardiovascular and metabolic functions by leptin in mice with leptin receptor deletion in POMC neurons Hypertension 2009; 54:e1022009
do Carmo JM, da Silva AA, Hall JE. Cardiovascular and metabolic regulation in mice with Shp2 deletion in forebrain neurons FASEB J. 2009; 23:785.52009
Dubinion JH, da Silva AA, do Carmo JM, Hall JE. Cardiovascular and metabolic responses to chronic central infusion of leptin in rats fed a high fat diet FASEB J. 2009; 23:1015.52009
Dubinion JH, da Silva AA, do Carmo JM, Hall JE. Cardiovascular and metabolic responses to chronic cPYY infusion FASEB J. 2009; 23:983.42009
do Carmo JM, Hall JE, da Silva AA. Chronic central leptin infusion restores sympatho-vagal balance, cardiovascular variability, and baroreflex sensitivity in diabetic rats Am J Physiol: Heart Circ Physiol. 2008; 295:H1974-H19812008
do Carmo JM, da Silva AA, Hall JE. Impaired baroreflex sensitivity and absence of hypertension in old leptin deficient obese mice Hypertension. 2008; 52:e104.P2442008
Hall JE. Obesity, hypertension and renal hemodynamics Proceedings of the International Society of Hypertension Nexus Symposium, Dublin, Ireland, 20082008
Dubinion J, Silva A, Dreher A, Hall JE. Cardiovascular and metabolic responses to chronic central MC3/4R antagonism in rats fed a high fat diet FASEB J. 2008; 22:947.42008
do Carmo JM, da Silva AA, Brandon E, Hall JE. Cardiovascular function and metabolism in old melanocortin-4 receptor deficient obese mouse FASEB J. 2008; 22:947.22008
da Silva AA, do Carmo JM, Freeman JN, Hall JE. Chronic MC3/4R activation does not mimic the actions of leptin on baroreceptor sensitivity and heart rate regulation in diabetic rats FASEB J. 2008; 22:947.52008
Hall ME, Hall JE, Smith G, Stec D. Rapid cardiac dysfunction caused by inducible cardiac specific leptin receptor deletion FASEB J. 2008; 22:743.32008
Brandon E, do Carmo JM, da Silva AA, Hosler JP, Hall JE. Renal lipid accumulation and mitochondrial function in leptin deficient and melanocortin-4 deficient obese mice FASEB J. 2008; 22:947.32008
Lee JH, Liu J, Taylor HA, Hall JE, Dubbert P, Crook E, Garrison R. Insulin Resistance and Obesity in Relation to Cardiovascular Disease Risk Factors in Non-Diabetic Overweight/Obese Participants of Jackson Heart Study Circulation 20082008
do Carmo JM, da Silva AA, Hall JE. Protection against obesity and hypertension induced renal injury in melanocortin 4-deficient mice treated with L-NAME Proceedings of Jackson Cardiovascular-Renal Meeting, Jackson, MS, USA, 20082008
Hall JE. Renal-pressure natriuresis - An infinite gain feedback mechanism for long-term blood pressure regulation? Proceedings of International Society of Nephrology Nexus Symposium, Vienna, Austria, 20072007
da Silva AA, Brandon E, do Carmo JM, Hall JE. Endogenous activity of the CNS melanocortin system contributes to the elevated arterial pressure in spontaneously hypertensive rats Proceedings of the Inter-American Society of Hypertension, Miami, FL, May 20072007
Ying Z, Ryan MJ, Webb RC, Hall JE. Inhibitor kappaB kinase 2 (IKK2) is necessary for vasoconstriction FASEB J. 2007; 21:lb5392007
Brandon EL, Cantwell L, Gu JW, Hall JE. Obesity enhances melanoma tumor growth independently of circulating leptin FASEB J. 2007; 21:763.32007
daSilva AA, Tallam LS, Liu J, Brandon E, Hall JE. A functional melanocortin system is required for the CNS actions of leptin on peripheral glucose regulation and cardiovascular function FASEB J. 2006; 20:A11682006
Tallam LS, Roberts JV, daSilva AA, Hall JE. Impact of obesity on renal structure and function in the absence of hypertension: Eidence from the melanocortin-4 receptor (MC4R) deficient mice FASEB J. 2006; 20:A11682006
daSilva AA, Tallam LS, Liu J, Hall JE. CNS actions of leptin play a major role in peripheral glucose regulation independent of adrenergic activation Hypertension. 2005; 46:8232005
daSilva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Role of the central melanocortin system in regulating arterial pressure in SHR Hypertension. 2005; 46:8672005
Tallam LS, daSilva AA, Hall JE. Role of the melanocortin-4 receptor in mediating the chronic cardiovascular and metabolic actions of leptin Hypertension. 2005; 46:8222005
daSilva AA, Kuo JJ, Tallam LS, Brown P, Liu J, Hall JE. Chronic cardiovascular, metabolic and renal actions of central hyperleptinemia in type-1 diabetic rats FASEB J. 2005; 19:A6312005
Tallam LS, Stec DE, daSilva AA, Hall JE. Renal changes in melanocortin-4 receptor (MC4R(-/-)) deficient mice that are severly obese but not hypertensive FASEB J. 2005; 19:A15812005
Liu J, da Silva AA, Meng S, Hall JE. Chronic central hyperinsulinemia transiently decreases food intake without changing arterial pressure or heart rate in rats Hypertension. 2004; 44:5602004
Gu JW, Gadonski G, Granger JP, Kodali M, Fortepiani L, Hall JE. Exercise training reduces blood pressure in LDLR gene knockout (-/-) mice Hypertension. 2004; 44:5072004
Tallam LS, Stec DE, da Silva AA, Kuo JJ, Hall JE. Melanocortin-4 receptor deficient mice are neither hypertensive nor salt-sensitive despite obesity, insulin resistance and hyperleptinemia Hypertension. 2004; 44:5032004
Meng S, da Silva AA, Liu J, Tallam LS, Hall JE. Role of oxidative stress in mediating chronic cardiovascular actions of leptin Hypertension. 2004; 44:5042004
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Chronic cardiovascular and dietary responses to activation of melanocortin 3/4 receptors in a model of diet-induced obesity J Hypertens. 2004; 22 (suppl I):s2022004
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Blood pressure regulation in rats whose mothers were fed a low protein diet during gestation; role of endothelin-1 FASEB J. 2004; 18:A7382004
Kuo JJ, Silva AA, Tallam LS, Hall JE. Chronic cardiovascular and renal actions of melanin concentrating hormone FASEB J. 2004; 18:A2972004
Liu J, Hall JE. Mechanical stretch and oleic acid interact to syimulate TGF-1 and collagen I formation in glomerular mesangial cells and this response is blocked by PPAR activation FASEB J. 2004; 18:A3032004
Tallam LS, Kuo JJ, Silva AA, Hall JE. Role of agouti related peptide in chronic regulation of cardiovascular and renal function FASEB J. 2004; 18:A2942004
Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in cardiovascular and renal responses to chronic hypothalamic melanocortin receptor activation Hypertension. 2003; 42:4222003
da Silva AA, Kuo JJ, Tallam LS, Hall JE. The role of endothelin-1 in blood pressure regulation in a rat model of diet-induced visceral obesity and hypertension Hypertension. 2003; 42:3942003
Hildebrandt D, Henegar J, Hall JE. Chronic increases in intrarenal angiotensin II do not cause renal injury independent of hypertension Proc Inter-American Soc Hyper. 2003, p.732003
Silva AA, Kuo JJ, Hall JE. Hypothalamic melanocortin-3/4 receptor inhibition abolishes the dietary and cardiovascular responses to chronic leptin infusion Proc Inter-American Soc Hyper. 2003, p.892003
De Paula RB, da Silva AA, Hall JE. Role of aldosterone in obesity-induced hypertension Proc Inter-American Soc Hyper. 2003; 502003
Gu, JW, Fortepiani L, Reckelhoff JF, Adair TA, Wang J, Hall JE. Increased expression of vascular endothelial growth factor (VEGF) and capillary density in heart of spontaneously hypertensive rats FASEB J. 2003; 17:A8452003
Liu J, Kuo J, Dai Y, Klett C, Hall JE. Mechanical stretch enhances angiotensin II stimulated TGF-b1, collagen IV production, and upregulation of AT1 receptor in mesangial cells FASEB J. 2003; 17:A4882003
Hall JE, Kuo J, da Silva A, Tallam L, Liu J, Dai Y. Obesity hypertension, sympathetic activation and neuroendocrine pathways Clin Auton Res. 2003; 13:1122003
Kuo JJ, Silva AA, Hall JE. Chronic cardiovascular and renal responses to melanocortin-4 receptor activation or inhibition Hypertension. 2002; 40:3862002
Kuo JJ, Silva A, Hall JE. Cardiovascular and renal responses to chronic hypothalamic melanocortin-4 blockade FASEB J. 2002; 16:A7932002
Gu JW, Wang J, Stockton A, Adair TH, Henegar L, Hall JE. Comparison of gene expression profiles in kidney cortex and medulla of obese and lean dogs FASEB J. 2002; 16:A8202002
Liu J Kuo J, Tang J, Henegar L, Hall JE. Increases expression of heat shock protein 47, mitogen-sctivated kinase-1, and collagen IV in mesangial cells after sustained mechanical stretch FASEB J. 2002; 16:A922002
Liu J Kuo J, Tang J, Henegar L, Hall JE. Sustained mechanical stretch upregulates expression of TGF-β and TGF-β type I receptors in glomerular mesangial cells FASEB J. 2002; 16:A932002
Klett CP, Kelley KL, Sirous ZN, Henegar L, Hall JE. Gene expression profiling in renal cortex and inner medulla of lean and obese dogs Hypertension. 2001; 38:4782001
Carlyle ME, Jones OB, Kuo JJ, Hall JE. Role of adrenergic activity in mediating chronic cardiovascular actions of leptin Hypertension. 2001; 38:5062001
Fitzgerald SF, Henegar JR, Brands MW, Henegar LK, Hall JE. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats J Hypertens. 2001; 19:s952001
Kuo JJ, Jones OB, Hall JE. Chronic cardiovascular and renal actions of leptin during hyperinsulinemia FASEB J. 2001; 15:A4662001
Gu JW, Wang J, Lokitz B, Al-Turk A, Adair TH, Henegar L, Hall JE. Expression profile arrays of 375 genes in kidney medulla of obese and lean dogs FASEB. J. 2001; 15:A7872001
Hussain T, Lokhandwala MF, Henegar J, Henegar L, Hall JE. Increased expression of Na, H-exchanger and Na,K-ATPase in renal cortex of obese dogs fed a high fat diet FASEB. J. 2001; 15:A1342001
Henegar JR, Hall JE. Ultrastructural changes in the glomerulus in the early stages of obesity FASEB J. 2001; 15:A8342001
Hall JE. Renal mechanisms of obesity hypertension Kidney Blood Press Res. 2000; 23:511999
Khalil RA, Crews JK, Carroll JF, Hall JE. Enhancement of Ca++ entry mechanisms of arterial vasoconstriction with low salt diet. Effect of obesity Hypertension. 1999; 33:10811999
Young A, Kolterman O, Hall JE. Amylin- innocent in essential hypertension? Diabetologia. 1999; 42:10291999
Hall JE. Basic science review of salt intake and cardiovascular disease Am J Hypertension. 1999; 12:231A1999
Hall JE. Obesity, hypertension and end-stage renal disease Proc XIII Scientific Meeting Inter-American Soc. Hypertension. 1999; 96A1999
Shek EW, Kim PK, Hall JE. Adrenergic blockade prevents leptin-induced hypertension Fed Proc. 1999; 13:A4561999
Fitzgerald SM, Hall JE, Brands MW. Rapid hypotensive response to fasting in spontaneously hypertensive rats (SHR) Fed Proc 1999; 13:A4571999
Hildebrandt DA, Kirk D, Hall JE. Renal and cardiovascular responses to chronic increases in cerebrovascular free fatty acids Fed Proc. 1999; 13:A7801999
Henegar JR, Hall JE. Role of endothelin in blood pressure control in lean and obese dogs Fed Proc. 1999; 13:A7811999
Hall JE, Jones DW, Fletcher BW, Cameron J, Mehrotra BD, Mehrotra B, Kirchner KA. Jackson Heart Study symposium on cardiovascular disease in African-Americans Am J Med Sci. 1999; 317:1411999
Shek EW, Keen HL, Brands MW, Hall JE. Blockade of nitric oxide synthesis amplifies insulin-induced hypertension in rats Hypertension. 1998; 32:5921998
Tyagi SC, Mujumdar VS, Shek EW, Brands MW, Hayden MR, Hall JE. Hyperhomocyst(e)inemia induces cardiovascular hypertrophy, fibrosis and hypertension Hypertension. 1998; 32:6291998
Wofford MR, Adair C, Anderson DC, Hall JE, Miller MM, Jones DW. α and β adrenergic blockade in obese and lean hypertensive subjects Hypertension. 1998; 32:5951998
Brands MW, Keen HL, Hailman AE, Hall JE. Chronic intravenous glucose infusion raises blood pressure in rats FASEB J. 1998; 12:A941998
Shek EW, Hall JE, Mujumdar VS, Tyagi SC. Hyperhomocysteinemia alters renal hemodynamics and cardiovascular function FASEB J. 1998; 12:A421998
Tyagi SC, Mujumdar VS, Smiley LM, Coleman TG, Hall JE. Hyperhomocysteinemia causes endothelial injury and vascular dysfunction FASEB J. 1998; 12:A3281998
Hall JE, Henegar JR, Shek EW, Brands MW. Role of renin-angiotensin system in obesity hypertension Circulation. 1997; 96:I-331997
Shek EW, Brands MW, Hall JE. Cardiovascular and renal actions of chronic central nervous system leptin infusion Hypertension. 1997; 30:4721997
Henegar JR, Shek EW, Henegar L, Hall JE. Renal functional and structural changes in the early stages of obesity Hypertension. 1997; 30:4741997
Hall JE. Cardiovascular and renal pathophysiology of obesity Am J Hypertens. 1997; 10:234A1997
Shek EW, Keen HL, Henegar JR, Brands MW, Hall JE. Does increased leptin contribute to obesity hypertension? FASEB J. 1997; 11:A2581997
Keen HL, Brands MW, Shek EW, Hall JE. Maintenance of baseline angiotensin II potentiates insulin-hypertension FASEB J. 1997; 11:A2581997
Hall JE. Renal mechanisms of obesity hypertension and relevance to essential hypertension Proc. XXXIII Internat. Cong. Physiol. Sci., L058.02, 19971997
Hall JE, Van Vliet BN, Garrity CA, Brands MW. Obesity hypertension- Role of adrenergic mechanisms Hypertension. 1996; 21:5281996
Keen Hl, Brands MW, Shek EW, Hall JE. Thromboxane synthesis is required for full expression of angiotensin-hypertensin Hypertension. 1996; 28:5371996
Zappe DH, Capel WT, Keen HL, Shek EW, Brands MW, Hall JE. Role of renal afferent nerves in obesity-induced hypertension Am J Hypertens. 1996; 9:20A1996
Coleman F, Alonso-Galicia M, Summers RL, Coleman TG, Hall JE. A computer simulation of the role of renal medullary compression in obesity hypertension FASEB J. 1996; 10:A3971996
Shek EW, Keen HL, Brands MW, Hall JE. Inhibition of nitric oxide synthesis enhances insulin-hypertension in conscious rats FASEB J. 1996; 10:A5561996
Keen HL, Brands MW, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats FASEB J. 1996; 10:A5561996
Summers RL, Woodward LH, Sanders DY, Hall JE. Using graphical analysis for the study of metabolic states FASEB J. 1996; 10:A2641996
Keen HL, Brands MW, Alonso-Galicia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension Hypertension. 1995; 26:5521995
Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats is dependent on angiotensin II Hypertension. 1995; 26:5541995
Brands MW, Gardner AL, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Chronic ACE inhibition prevents insulin-hypertension in Sprague-Dawley rats Am J Hypertens. 1995; 8:55A1995
McKay MK, Hall JE, Hester RL. Alterations in arteriolar diameter by insulin in the cremaster muscle FASEB J. 1995; 9:A201995
Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats FASEB J. 1995; 9:A2971995
Zappe DH, Kassab SE, Brands MW, Hall JE. Chronic adrenergic blockade attenuates the development of hypertension due to weight gain in dogs FASEB J. 1995; 9:A2961995
Alonso-Galicia M, Brands MW, Smith MJ, Zappe DH, Hall JE. Chronic AT1 receptor blockade in obese Zucker rats FASEB J. 1995; 9:A2961995
Hall JE. Insulin resistance and hypertension in the elderly Proceedings from the Internatonal Congress of Hypertension in the Elderly. 1995. p 531995
Hall JE. Mechanisms of obesity-associated hypertension and relevance to essential hypertension Proceedings from the XIII International Congress of Nephrology. 1995. p 321995
Kassab SE, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Bilateral renal denervation prevents the development of obesity-induced hypertension in dogs Hypertension. 1994; 3:3751994
Alonso-Galicia M, Dwyer TM, Hererra GA, Hall JE. Increased hyaluronic acid in the inner medulla of obese dogs Hypertension. 1994; 3:4021994
Hall JE, Garrity CA, Zappe DH, Brands MW. Long-term systemic hemodynamic actions of insulin: Role of nitric oxide and B-adrenergic mechanisms Hypertension. 1994; 3:3751994
Hall JE. Neurohumoral and renal mechanisms of obesity hypertension Am J Hypertens. 1994; 7:26A1994
Kassab S, Wilkins C, Kato T, Mizelle L, Hall J, Granger J. Renal nerves play an important role in mediating the sodium retention in response to a high fad diet in conscious dogs Am J Hypertens. 1994; 7:26A1994
Alonso-Galicia M, Dwyer TM, Herrera G, Hall JE. Altered renal medullary glycosaminoglycan (GAG) content in obese dogs FASEB J. 1994; 8:A5801994
Zappe DH, Garrity CA, Brands MW, Hall JE. Role of B-adrenergic systems in mediating chronic systemic hemodynamic effects of insulin FASEB J. 1994; 8:A5271994
Kassab S, Wilkins C, Kato T, Mizelle L, Hall J, Granger JP. Role of renal nerves in mediating the sodium retention in obese dogs FASEB J. 1994; 8:A5271994
Brands MW, Harrison DA, Hall JE. Sustained intrarenal calcium infusion does not lower arterial pressure in normal dogs FASEB J. 1994; 8:A5271994
Hildebrandt DA, Heath BJ, Hall JE. Systemic arterial pressure and heart rate responses to acute and chronic carotid or vertebral artery insulin infusion FASEB J. 1994; 8:A5281994
Mitchell CL, Garrity CA, Zappe D, Brands MW, Hall JE. Adrenergic mechanisms contribute to obesity-induced hypertension MS Acad Sci. 1994; 39:551994
Torrey C, Van Vliet BN, Garrity CA, Hall JE. Cholinergic control of heart rate in obesity MS Acad Sci. 1994; 39:541994
Garrity CA, Brands MW, Hall JE. Chronic blockade of endothelial-derived nitric oxide (EDNO) in obese and normal dogs MS Acad Sci. 1994; 39:551994
Holman MG, Brands MW, Garrity CA, Hall JE. Chronic hyperinsulinemia has an exaggerated pressor and chronotropic effect in SHR compared to WKY rats MS Acad Sci. 1994; 39:541994
Alonso-Galicia M, Dwyer TM, Hall JE. Estimation of renal medullary glycosaminoglycan (GAG) content in obese dogs MS Acad Sci. 1994; 39:531994
Arnold MD, Brissie R, Soonz JS, Dwyer T, Hall J, Herrera GA. Obesity associated renal medullary changes Lab Investigations. 1994; 70:156A1994
Hall JE, Garrity CA, Brands MW. Renal and systemic hemodynamics during chronic endothelial derived nitric oxide (EDNO) blockade in obesity hypertension Proceedings from the 15th Meeting of the International Society of Hypertension. 19941994
Hall JE. Resistance to metabolic actions of insulin: A cause or a consequence of hypertension Proceedings from the 76th Meeting of the Endocrine Society. 1994; 1901994
Keen HL, Brands MW, Harrison DL, Hall JE. Sympathetic blockade prevents the chronotropic but not the pressor response to chronic insulin infusion in rats MS Acad Sci. 1994; 39:541994
Brands MW, Garrity CA, Hall JE. High-fructose diet does not cause hypertension in rats Am J Hypertens. 1993; 6:59A1993
Hall JE, Van Vliet BN, Garrity CA, Brands MW. Adrenergic mechanisms and obesity-induced hypertension FASEB J. 1993; 7:A1881993
Van Vliet BN, Torrey C, Hall JE. Autonomic determinants of resting heart rate in obese dogs FASEB J. 1993; 7:A6241993
Brands MW, Garrity C, Holman MG, Hall JE. Exaggerated pressor response to chronic hyperinsulinemia in SHR versus WKY rats FASEB J. 1993; 7:A61993
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Systemic hemodynamic actions of long-term intravertebral angiotensin II infusion FASEB J. 1993; 7:A4051993
Hall JE, Connell RD, Garrity CA, Brands MW. Endothelial-derived relaxing factor (EDRF) in long-term circulatory control in normal and obese dogs Circulation. 1992; 86:I4891992
Hall JE, Van Vliet BN, Garrity CA, Connell RD, Brands MW. Role of increased adrenegic activity in obesity-induced hypertension Circulation. 1992; 86:I5411992
Hall JE. The kidney, obesity, and essential hypertension Hypertension. 1992; 19 (Suppl. 1): I-11992
Gahnem FJ, Hall JE, Sealey JE. High fat diet increases plasma prorenin in normal dogs Am J Hypertens. 1992; 5:54A1992
Hildebrandt DA, Van Vliet BN, Brands MW, Mizelle HL, Hall JE. Chronic intravertebral (IVT) angiotensin II infusion increases arterial pressure FASEB J. 1992; 6:A14691992
Dzielak DJ, Doherty MC, Callahan J, Hall JE. Partial renal infarct hypertension does not develop in animals treated with DUP-753 FASEB J. 1992; 6:A9451992
Brands MW, Alonso-Galicia M, Mizelle HL, Hildebrandt DA, Hall JE. Renal perfusion pressure and sodium balance in DOCA-salt sensitive hypertension FASEB J. 1992; 6:A14691992
Summers RL, Montani JP, Hall JE. Theoretical analysis of the mechanisms of steady-state insulin resistance FASEB J. 1992; 6:A14921992
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Blood pressure regulation during chronic hyperinsulinemia in obese, insulin resistant dogs Proceedings from the XIV Meeting of the International Society of Hypertension. 1992, p 2241992
Hall JE, Herrera GA, Granger JP. Renal pathophysiology in obesity-induced hypertension Hypertension. 1991; 18:3951991
Brands MW, Hall JE, Hildebrandt DA, Mizelle HL. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive Am J Hypertens. 1991; 4:13A1991
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Renal function in obesity-associated hypertension in conscious dogs Am J Hypertens. 1991; 4:118A1991
Brands MW, Hall JE, Mizelle HL, Hildebrandt DA. Chronic angiotensin converting enzyme inhibition (ACEI) improves cardiac output and fluid balance during heart failure FASEB J. 1991; 5:A7381991
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Hyperinsulinemia does not elevate blood pressure in obese hypertensive dogs FASEB J. 1991; 5:A7371991
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Low salt diet abolishes the renal response to urodilation FASEB J. 1991; 5:A10191991
Mizelle HL, Montani JP, Hester RL, Hall JE. Renal hemodynamics and sodium excretion during chronic reductions in renal perfusion pressure FASEB J. 1991; 5:A7371991
Miller BA, Dixon WN, Brands MW, Mizelle HL, Hildebrandt DA, Hall JE. Control of arterial pressure and renal function during hyperinsulinemia in obese dogs MS Acad Sci. 1991; 36:461991
Dixon WN, Brands MW, Miller BA, Mizelle HL, Hildebrandt DA, Hall JE. Renal and systemic hemodynamics in obesity-associated hypertension MS Acad Sci. 1991; 36:461991
Mizelle HL, Montani JP, Hester RL, Hall JE. Role of renal perfusion pressure in long-term control of sodium excretion Hypertension. 1990; 16:3271990
Mizelle HL, Gaillard CA, Manning RD, Hall JE. ANP decreases cardiac output independent of blood volume changes in conscious nephrectomized dogs Am J Hypertens. 1990; 3:82A1990
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia and blood pressure regulation Am J Hypertens. 1990; 3:26A1990
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia Am J Hypertens. 1990; 3:19A1990
Mizelle HL, Brands MW, Gaillard CA, Manning RD, Dixon WN, Hildebrandt DA, Hall JE. Chronic hemodynamic actions of the atrial natriuretic peptide (ANP) FASEB J. 1990; 4:A6941990
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Comparison of the renal action of urodilation (URD) and atrial natriuretic peptide (ANP) FASEB J. 1990; 4:A6951990
Brands MW, Hall JE, Hildebrandt DA, Mizelle HL. Hypertension during chronic hyperinsulinemia in conscious rats FASEB J. 1990; 4:A8171990
Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Salt-induced hypertension: Role of pressure natriuresis FASEB J. 1990; 4:A8171990
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Control of arterial pressure during chronic intrarenal or systemic hyperinsulinemia J Hypertens. 1990; 8 (Suppl. 3): 591990
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. Hemodynamic responses to chronic hyperinsulinemia Proceedings from the XI International Society of Hypertension. 1990; p 1601990
Hall JE, Dixon WN, Brands MW, Mizelle HL, Hildebrandt DA. Obesity, hyperinsulinemia, and hypertension: Control of renal function and systemic hemodynamics J Am Soc Nephrol. 1990; 1:4901990
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Renal pressure natriuresis and urodilation: A new natriuretic hormone J Am Soc Nephrol. 1990; 1:4171990
Hall JE. Renal vasodilation: Pathophysiological and therapeutic implications Eur J Pharmacol. 1990; 183:451990
Mizelle HL, Brands MW, Hildebrandt DA, Hall JE. Role of renal perfusion pressure in chronic hypercalcuria J Am Soc Nephrol. 1990; 1:4961990
Gaillard CA, Hall JE, Mizelle HL, Hildebrandt DA, Montani JP. Atrial natriuretic factor and long-term blood pressure control: Interaction with renin-angiotensin-aldosterone system Kidney Int. 1990; 37:3391990
Hall JE. What is the role of the intrarenal renin-angiotensin system in blood pressure control? Pediatr Nephrol. 1990; 4:871990
Gaillard CA, Hall JE, Mizelle HL, Hildebrandt DA, Montani JP. Chronic low dose ANF infusion causes hypotension in sodium depleted dogs Am J Hypertens. 1989; 2:33A1989
Hall JE, Brands MW, Kivlighn SD, Hildebrandt DA, Mizelle HL, Gaillard CA. Hyperinsulinemia, catecholamines, and long-term blood pressure regulation Am J Hypertens. 1989; 2:32A1989
Mizelle HL, Hall JE, Hildebrandt DA, Montani JP. Renal hemodynamics and electrolyte excretion during chronic intrarenal infusion of atrial natriuretic peptide (ANP) FASEB J. 1989; 3:A6971989
Hall JE. Angiotensin II and renal pressure natriuresis mechanism in long-term control of arterial pressure Proceedings of the XXXI International Congress of Physiological Sciences. 1989; p 261989
Smith CD, Mizelle HL, Hildebrandt DA, Hall JE. Angiotensin-adenosine interactions in the renal vasculature: Mechanisms of calcium activation Kidney Int. 1989; 35:4741989
Hall JE, Coleman TG, Mizelle HL. Arterial pressure and renal function during chronic hyperinsulinemia Kidney Int. 1989; 35:3261989
Mizelle HL, Hall JE, Hildebrandt DA, Hall JE. Does atrial natriuretic peptide (ANP) cause chronic natriuresis? Kidney Int. 1989; 35:2951989
Hall JE, Mizelle HL. Arterial pressure and renal function during chronic renin inhibition in conscious dogs Hypertension. 1988; 12:3401988
Hall JE, Coleman TG, Mizelle HL. Does chronic hyperinsulinemia cause hypertension? Am J Hypertens. 1988; 1:46A1988
Mizelle HL, Hall JE, Hildebrandt DA, Smith CD. Interactions between atrial natriuretic factor, pressure natriuresis, and the renin-angiotensin system Am J Hypertens. 1988; 1:102A1988
Hall JE, Coleman TG, Brown CA, Mizelle HL. Arterial pressure regulation during chronic hyperinsulinemia FASEB J. 1988; 2:A12791988
Mizelle, HL, Hall JE, Montani JP. Renal function and the renin-angiotensin system in a model of chronic compensated congestive heart failure FASEB J. 1988; 2:A13201988
Guyton AC, Hall JE, Coleman TG, Norman Jr. RA, Montani JP. Long-term arterial pressure regulation and hypertension - A computer and experimental study Proceedings from Symposium on Frontiers in Cardiopulmonary Mechanics. 1988; p 151988
Hall JE, Mizelle HL, Woods LL, Montani JP. Regulation of Na balance in norepinephrine hypertension: Role of pressure natriuresis Kidney Inter. 1988; 33:2961988
Woods LL, Mizelle HL, Hall JE. Role of increased renal artery pressure in control of sodium excretion during ACTH hypertension Kidney Int. 1988; 33:4301988
Woods LL, Mizelle HL, Hall JE. Role of the liver in controlling renal hemodynamics during amino acid infusion Fed Proc. 1987; 46:6371987
Mizelle HL, Hall JE, Montani JP, Woods LL. Role of the renal nerves in the sodium retention of congestive heart failure Fed Proc. 1987; 46:12351987
Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics during amino acid infusion: Role of the liver Kidney Int. 1987; 31:4271987
Hall JE. Arterial pressure and body fluid homeostasis Fed Proc. 1986; 45:2862-28631986
Mizelle, HL, Woods LL, Montani JP, Hall JE. Interactions between angiotensin and the renal nerves during chronic sodium restriction Fed Proc. 1986; 45:5391986
Woods LL, Mizelle HL, Hall JE. Tubuloglomerular feedback control of renal hemodynamics during hyperglycemia Fed Proc. 1986; 45:5151986
Woods LL, Mizelle HL, Hall JE. Mechanisms controlling renal hemodynamic responses to amino acids and glucose: Role of tubuloglomerular feedback Proceedings from the International Union of Physiological Scientists. 1986; 16:291986
Montani JP, Hall JE, Guyton AC. NA/K ATPase inhibition and long-term blood pressure control Proceedings from the International Union of Physiological Scientists. 1986; 16:6021986
Hall JE, Mizelle HL, Woods LL. Renal actions of angiotensin and aldosterone Proceedings from the International Union of Physiological Scientists. 1986; 16:3751986
Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics during hyperglycemia: Role of macula densa feedback Kidney Int. 1986; 29:3891986
Montani JP, Hall JE, Guyton AC. Na/K pump inhibition with reduced renal mass does not produce chronic hypertension Kidney Int. 1986; 29:2531986
Mizelle HL, Woods LL, Montani JP, Dzielak DJ, Hall JE. Role of the renal nerves in adaption to chronic sodium restriction Kidney Int. 1986; 29:2531986
Hall JE, Montani J-P, Woods LL, Mizelle HL. Control of fluid balance in vasopressin hypertension: Role of renal perfusion pressure Fed Proc. 1985; 44:10111985
Woods LL, Mizelle HL, Montani JP, Richards RM, Cornell JE, Hall JE. Control of renal hemodynamics and electrolyte excretion during amino acid infusion Fed Proc. 1985; 44:17391985
Montani JP, Hall JE, Guyton AC. Na/K pump inhibition increases vascular reactivity but does not produce chronic hypertension Fed Proc. 1985; 44:15551985
Mizelle HL, Woods LL, Montani JP, Hall JE. Role of renal nerves in adaptation to chronic sodium deprivation Fed Proc. 1985; 44:10111985
Hall JE, Montani JP. Role of increased renal arterial pressure in escape from antidiuretic effects of vasopressin Kidney Int. 1985; 27:1921985
Hall JE, Granger JP, Montani JP, Premen AJ. Renal hemodynamic actions of adenosine: Interactions with angiotensin and tubuloglomerular feedback Fed Proc. 1984; 43:4091984
Premen AJ, Hall JE. Role of adenosine in autoregulation of glomerular filtration rate and renal blood flow Kidney Int. 1984; 25:2911984
Dzielak DJ, Norman Jr RA, Hall JE. Servo-occluder technique for characterization of arterial pressure changes caused by CNS ischemia Fed Proc. 1984; 43:6941984
Hall JE, Montani JP. Adaptation of renal excretion to chronic servo-controlled reduction in perfusion pressure: Role of GFR autoregulation and decreased tubular reabsorption Proceedings of the X International Society of Hypertension. 1984; 4231984
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and diuresis, role of renal artery pressure in anesthetized dogs Proceedings from the 10th International Society of Hypertension. 1984; 1111984
Hall JE, Montani JP. GFR autoregulation during long-term reductions in renal perfusion pressure The Physiologist. 1984; 27:2081984
Hall JE, Montani JP. Long-term renal autoregulation and adaptation to decreased renal perfusion pressure Proceedings from the IX International Congress of Nephrology. 1984; 3941984
Guyton AC, Hall JE, Jackson TE. Renal afferent and efferent arteriolar control of arterial pressure Proceedings from the 10th International Society of Hypertension. 1984; 4211984
Premen AJ, Hall JE, Smith MJ, Rushing P. Role of glucagon during protein-induced elevations in renal blood flow and glomerular filtration rate The Physiologist. 1984; 27:2081984
Montani JP, Nuwayhid BS, Summers RL, Markov AK, Hall JE, Guyton AC. Role of Na/K ATPase activity in long-term blood pressure control Proceedings from IX International Congress of Nephrologists.1984; 3941984
Olsen ME, Hall JE, Montani JP, Cornell J. Role of renal prostaglandins in selective protection of preglomerular vessels from angiotensin II vasoconstriction Proceedings from IX International Congress of Nephrology. 1984; 4581984
Hall JE, Granger JP, Premen AJ. Mechanisms of aldosterone escape: Role of glomerular filtration and arterial pressure Kidney Int. 1984; 25:2001984
Coleman TG, Davis JR MH, Hall JE. Rapid plasma renin activity changes during hemorrhage in the rat Fed Proc. 1983; 42:3181983
Hall JE, Granger JP. Role of peripheral sympathetic nervous system in mediating the chronic blood pressure and renal hemodynamic effects of angiotensin II Fed Proc. 1983; 42:5891983
Granger JP, Hall JE. Role of renin-angiotensin system and tubuloglomerular feedback in altering the renal responses to glandular kallikein Fed Proc. 1983; 42:5901983
Hall JE, Granger JP, Premen AJ. Angiotensin II constricts preglomerular vessels in the presence of adenosine The Physiologist. 1983; 26:A1271983
Premen AJ, Hall JE, Granger JP. Control of arterial pressure and renal hemodynamics during chronic intrarenal adenosine infusion The Physiologist. 1983; 26:A1271983
Hall JE, Granger JP. Mechanisms of escape from chronic sodium retaining effects of angiotensin II Proceedings from the 29th Congress of the International Union of Physiogical Sciences. 1983; 3181983
Olsen ME, Hall JE, Montani JP, Guyton AC. Natriuretic and antinatriuretic actions of angiotensin II: Role of renal artery pressure and proximal tubular reabsorption The Physiologist. 1983; 26:A1271983
Granger JP, Hall JE. Control of renal hemodynamics, electrolyte excretion, and arterial pressure during acute and chronic intrarenal infusion of glandular kallikrein Kidney Int. 1983; 23:2791983
Hall JE, Granger JP. Escape from the chronic sodium retaining actions of angiotensin IIL role of increased renal arterial pressure Kidney Int. 1983; 23:1701983
Hall JE, Granger JP, Twu B. Interactions between angiotensin II and intrinsic autoregulatory mechanisms in control of renal segmental resistances Fed Proc. 1982; 41:12571982
Granger JP, Hall JE, Twu B. Long-term control of renal hemodynamics, electrolyte excretion and arterial pressure by circulating bradykinin in conscious dogs Fed Proc. 1982; 41:12471982
Granger JP, Twu B, Hall JE. Control of renal segmental resistances by angiotensin II in the absence of tubuloglomerular feedback J MS Acad Sci. 1982; 27: 311982
Twu B, Granger JP, Hall JE. Renin secretion into the renal circulation and lymph during increased ureteral pressure J MS Acad Sci. 1982; 27:311982
Hall JE, Granger JP. Role of angiotensin II in mediating renal hemodynamic effects of adenosine The Physiologist. 1982; 25:3171982
Granger JP, Hall JE, Twu B. The role of circulating and endogenous kinins in long-term regulation of hemodynamics, electrolyte excretion, and arterial pressure in conscious dogs J MS Acad Sci. 1982; 27:321982
Kastner PK, Hall JE, Guyton AC. Autoregulation of glomerular filtration rate: Role of intrarenally formed angiotensin II Fed Proc. 1981; 40:5161981
Granger JP, Hall JE. Does azotemia potentiate the chronic blood pressure and renal vasoconstrictor effects of aniotensin II? Fed Proc. 1981; 40:4351981
Hall JE, Granger JP. Mechanisms of captopril's chronic blood pressure and renal hemodynamic effects Fed Proc. 1981; 40:4351981
Granger JP, Hall JE. Effects of azotemia on control of arterial pressure, renal hemodynamics, and electrolyte excretion by angiotensin II J MS Acad Sci. 1981; 26:581981
Hall JE, Granger JP. Mechanisms of the chronic blood pressure and renal hemodynamic effects of captopril (SQ-14225) Proceedings from the Eighth International Society of Hypertension. 1981; 1701981
Hall JE, Morse CL, Smith Jr. MJ, Young DB, Guyton AC. Regulation of renal hemodynamics, electrolyte excretion, and arterial pressure during chronic glucocorticoid excess Fed Proc. 1980; 39:9631980
Kastner PR, Hall JE, Guyton AC. Renin secretion and renal hemodynamics responses following step increases in renal venous pressure before and after angiotensin converting enzyme inhibition Fed Proc. 1980; 39:9491980
Hall JE, Guyton AC, Smith Jr. MJ, Coleman TG. Long-term relationships between arterial pressure, renal hemodynamics and sodium excretion: Role of renin-angiotensin system Proceedings from the Seventh International Society of Hypertension. 1980; 491980
Hall JE, Coleman TG, Guyton AC, Kastner PR, Salgado HC. Control of glomerular filtration rate by renin-angiotensin system: Role of circulating angiotensin II The Physiologist. 1979; 22:511979
Guyton AC, Lohmeier TE, Hall JE, Kastner PR, Hockel GM. Overall control of the circulation Proceedings from Australian Physiology and Pharmacology Society. 19791979
Coleman TG, Hall JE. Tubuloglomerular feedback does not explain autoregulation of renal blood flow and glomerular filtration rate The Physiologist. 1979; 22:211979
Hall JE, Guyton AC, Coleman TG, Smith MJ. Role of angiotensin and aldosterone in control of arterial pressure and renal hemodynamics during chronic converting enzyme inhibition Kidney Int. 1979; 16:7931979
Hall JE, Guyton AC, Coleman TG, McCaa RE. Long-term control of renal hemodynamics and electrolyte excretion during converting enzyme inhibition The Physiologist. 1978; 21:491978
Hall JE, Guyton AC, Salgado HC, Balfe JW, McCaa RE. Role of [Des-Asp1] angiotensin III (AIII) and Angtiotensin II (AII) in controlling renal hemodynamics and electrolyte excretion Fed Proc. 1978; 37:3071978
Guyton AC, Hall JE, Balfe JW, Lohmeier TE, Jackson TE, Norman Jr RA. Pathophysiological renal mechanisms that cause hypertension, hypotension, and uremia Proceedings from the VII International Congress of Nephrology. 1978 37:3071978
Coleman TG, Hall JE. Perfused tissues: constant flow vs. constant pressure systems Proceedings from Annual Conference of Engineering in Medicine and Biology. 1978; 20:2191978
Hall JE, Guyton AC, Coleman TG, McCaa RE. Long-term relationship between arterial pressure, urinary output, and renal hemodynamics after converting enzyme inhibition Kidney Int. 1978; 14:6961978
Trippodo NC, Hall JE, Lohmeier TE, Guyton AC. Effect of intrarenal blockade of angiotensin II on sodium excretion in dehydrated dogs Fed Proc. 1977; 36:5741977
Hall JE, Guyton AC, McCaa RE, Salgado HC. Control of renal hemodynamics and electrolyte excretion after converting enzyme inhibition The Physiologist. 1977; 20:401977
Hall JE, Guyton AC, McCaa RE, Salgado HC. Intrarenal role of the renin-angiotensin system Circulation. 1977; 56:2461977
Guyton AC, Hall JE, Lohmeier TE, Fagard RH, Cowley Jr. AW. Salt retention and gfr autoregulation mediated by efferent arteriolar effects of intrarenal renin-angiotensin Proceedings from International Union of Physiological Sciences. 1977; 13:2951977
Hall JE, Guyton AC, Salgado HC, McCaa RE. Changes in renal hemodynamics and body fluids during acute and chronic angiotensin II (AII) hypertension Kidney Int. 1977; 12:5001977
Hall JE, Guyton AC. Single injection clearances of 125I-Iothalamate Fed Proc. 1976; 35:5421976
Hall JE, Guyton AC. Uncoupling of renal blood flow (RBF) and glomerular filtration rate (GFR) autoregulation after renin depletion The Physiologist. 1976; 19:2171976
Hall JE, Guyton AC, Cowley Jr. AW, McCaa RE, McCaa CS. Intrarenal role of angiotensin II (AII) Kid Int. 1976; 10:5301976
Hall JE, Guyton AC, Jackson TE. Effects of increased plasma colloid osmotic pressure on renal hemodynamics and renin secretion The Physiologist. 1975; 18:2381975
Lalone B, Schwinghamer J, Hall J. Autoregulation of skeletal muscle blood flow during hemorrhage The Physiologist. 1974; 17:2701974
Hall J, Lalone B, Schwinghamer J, Adams T. Neurally and humorally mediated vascular responses to hemorrhage The Physiologist. 1973; 16:3331973
Musson, JB, Lalone B, Hall J, Schwinghamer J. Skin and muscle vascular responses to hypothermia The Physiologist. 1973; 16:4041973
Lalone B, Hall J, Musson J, Schwinghamer J. Vascular responses to adrenochrome in the dog forelimb Clin Res. 1973; 21:4311973
Hall J, Lalone B, Buck M, Schwinghamer J Mechanisms of large vessel constriction and fluid mobilization during hemorrhage The Physiologist. 1972; 15:1581972
Hall J, Lalone B, Buck M, Schwinghamer J Role of circulating constrictor agents in vascular response to hemorrhage Clin Res. 1972; 20:7191972

Book Chapter

Hall ME, Wang Z, do Carmo J, Kamimura D and Hall JE Obesity and metabolic syndrome hypertension In: Disorders of Blood Pressure Regulation: Phenotypes, Mechanisms, Therapeutic Options. Eds. AE Berbari, G Mancia. Springer Publishing. 2018; 705-722.2018
Hall JE, Granger JP, Jones DW, Hall ME Pathophysiology of hypertension. In: Hurst’s The Heart 14th ed., Eds. V. Fuster, R.Harrington, J Narula, Z. Eapen. McGraw-Hill Medical, New York. 2017; pp. 720-7502017
Hall ME and Hall JE Pathogenesis of Hypertension In: Hypertension: A Companion to Braunwald’s Heart Disease, 3rd edition, Eds. GL Bakris, M Sorrentino. Elsevier, Inc, Philadelphia. 2017; pp. 33-512017
Maric C, Hall JE. Obesity, metabolic syndrome and diabetic nephropathy. In: Diabetes and the kidney, contibutions to nephrology Eds. KN Lai, SCW Tang. Karger, Basel, 2011. pp. 28-352011
Hall JE, Granger JP, Jones DW, Hall ME. Pathophysiology of hypertension. In: Hurst’s the heart, 13th ed Eds. V Fuster, RA O’Rourke, RA Walsh, PA Poole-Wilson. McGraw-Hill Medical, New York, 2011. pp 1549-15842011
Hall ME, Hall JE, Granger JP, Jones DW. Systemic hypertension: pathogenesis and etiology In: Hurst’s The Heart Manual of Cardiology, 12th ed. Eds. R.A. O’Rourke, R.A. Walsh, V. Fuster. McGraw-Hill Medical, New York, pp 339-350, 20092009
Hester RL, Hall JE. Local autoregulation of blood flow In: Hypertension Primer, 4th edition, American Heart Assoc. Eds. J. L. Izzo Jr. and H. C. Black. pp. 129-132, 20082008
Hall JE, Granger JP, Hall ME, Jones DW. Pathophysiology of hypertension In: Hurst’s The Heart, 12th ed. Eds. V. Fuster, R.A. O’Rourke, R.A. Walsh, P.A. Poole-Wilson. McGraw-Hill Medical, New York, pp. 1570-1608, 20082008
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Hypertension Primer, 4th edition, American Heart Assoc . Eds. J. L. Izzo Jr. and H. C. Black. pp. 132-135, 20082008
Hall JE, daSilva AA, Brandon E, Stec DE, Ying Z, Jones DW. Pathophysiology of obesity hypertension and target organ injury In: Comprehensive Hypertension. Eds. Lip, G.Y.P. and J.E. Hall. Elsevier, New York, pp. 447-468, 20072007
Granger JP, Hall JE. Role of the kidney sodium and fluid excretion in hypertension In: Comprehensive Hypertension. Eds. Lip, G.Y.P. and J.E. Hall. Elsevier, New York, pp. 241-263, 20072007
Hall JE, Jones DW, Kuo JJ, da Silva AA, Liu J, Tallam L. Obesity and hypertension: impact on cardiovascular and renal disease In: Hypertension – a Companion to Brenner and Rector’s The Kidney. Eds. S. Oparil and M. Weber. Elsevier Science, Philadelphia. pp. 464-474, 20052005
Hall JE, Granger JP. Regulation of fluid and electrolyte balance in hypertension- role of hormones and peptides In: Hypertension- Principles and Practice. Eds. E.J. Battegay, G.Y.H.Lip, and G.L. Bakris. Taylor and Francis Group, LLC, Boca Raton. pp 121-142, 20052005
Hall JE, Jones DW, Henegar J, Dwyer TM, Kuo J. Obesity hypertension, and renal disease In: Obesity: Mechanisms and Clinical Management. Ed. R.H. Eckel, Lippincott, Williams & Wilkins, Philadelphia, pp. 273-300, 20032003
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Hypertension Primer, 3rd edition, American Heart Assoc. Eds. J. L. Izzo Jr. and H. C. Black. pp. 111-114, 20032003
Hall JE. Historical Perspective of the Renin-Angiotensin System In: Angiotensin Protocols- Methods in Molecular Medicine. Ed. D.H. Wang. Humana Press, Inc., p. 3-22, 20002000
Brands MW, Hall JE. Mechanisms for chronic antihypertensive effect of angiotensin II blockade In: Angiotensin II Receptor Antagonists. Ed. M. Epstein and H. R. Brunner, Hanley & Belfus, Inc., Philadelphia, p. 171-187, 20002000
Hall JE, Henegar JR, Shek EW, Brands MW. The renal circulation in obesity and insulin resistance In: Advances in Organ Biology: The Renal Circulation. Ed W.P. Anderson, JAI press, Greenwich, Connecticut, p. 383-397, 20002000
Hall JE, Brands MW. The renin-angiotensin-aldosterone system: renal mechanisms and circulatory homeostasis In: The Kidney: Physiology and Pathophysiology, 3rd Edition. Eds. D.W. Seldin and G. Giebisch. Raven Press, New York, p. 1009-1046, 20002000
Hall JE, Brands MW, Jones DW, Shek EW, Henegar JR. Mechanisms of obesity hypertension and relevance to essential hypertension In: Obesity: Impact on Cardiovascular Disease. Eds. G. Fletcher, S. Grundy, and L.Hayman. Futura Publishing Co., Inc., p133-153, 19991999
Hall JE. Cardiovascular and Renal Pathophysiology of Obesity In: ACE Inhibitors, Diabetes, and Obesity: Molecules, Metabolism, and Management1998
Hall JE, Brands MW, Shek EW, Henegar JR. Renal actions of angiotensin II and long-term blood pressure regulation In: Renin-Angiotensin, Ed. H. Ulfendahl and M. Aurell, Portland Press Ltd, London, p. 89-104, 19981998
Tyagi SC, Hayden MR, Hall JE. Role of angiotensin in angiogenesis and cardiac fibrosis in heart failure In: Angiotensin II Receptor Blockade: Physiological and Clinical Implications . Eds. N.S. Dhalla, P. Zahradka, I.M.C. Dixon, and R.E. Beamish. Progress in Experimental Cardiology 2:537-549, 19981998
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Primer on Hypertension, 2nd edition, American Heart Assoc.,Eds. J. L. Izzo Jr. and H. C. Black, p. 92-94, 19981998
Van Vliet BN, Hall JE, Lohmeier TE, Mizelle HL. Renal Circulation In: Nervous Control of Blood Vessels, Ed. T. Bennett and S. Gardiner. Harwood Academic Publishers, London, p. 371-433, 19961996
Hall JE, Guyton AC, Brands MW. Control of Sodium Excretion and Arterial Pressure by Intrarenal Mechanisms and the Renin-Angiotensin System. In: Hypertension: Pathophysiology, Diagnosis, and Management Eds. J.H. Laragh and B.M. Brenner. Raven Press, New York, 1995. p. 1451-14761995
Guyton AC, Hall JE, Coleman TG, Manning Jr. RD, Norman Jr. RA. The Dominant Role of the Kidneys in Long-term Arterial Pressure Regulation in Normal and Hypertensive States. In: Hypertension: Pathophysiology, Diagnosis and Management Eds. J.H. Laragh and B.M. Brenner. Raven Press, New York, 1995. p 1311-13261995
Hall JE, Granger JP. Role of Sodium and Fluid Excretion in Hypertension. In: Textbook of Hypertension Ed. J.D. Swales. Blackwell Scientific Pubs, Oxford, 1994. p 360-3841994
Hall JE, Brands MW. Intrarenal Actions of Angiotensin II: Physiology and Pathophysiology. In: Current Advances in ACE Inhibtion Ed. G.A. McGregor and P. Sever. Churchill Livingstone, London, 1993. p 41-511993
Hall JE, Brands MW. Intrarenal and Circulating Angiotensin II and Renal Function. In: The Renin-Angiotensin System Eds. J.I.S. Robertson and M.G. Nicholls. Gower Medical Publishing, London, 1993. Vol I, Chapter 26, p 1-431993
Coleman TG, Hall JE. Regional Blood Flow Regulation. In: Primer on Hypertension, American Heart Associaton Eds. J.L. Izzo, Jr. and H.C. Black. 1993. p 79-821993
Coleman TG, Hall JE. A Mathematicl Model of Renal Hemdynamics and Excretory Function. In: Computer Modeling of Comples Biological Systems. Vol. 11, (Ed.) Ed. Sl. Iyengary. CRC Press, 1992, p. 89-1241992
Hall JE, Guyton AC. The Kidney and Blood Pressure Regulation. In: Renovascular and Renal Parenchymatos Hypertension: Pathophysiology Diagnosis and Management Eds.: T.F. Luscher and N.M. Kaplan. Springer-Verlag Publishers, Berlin, 1992. p. 3-291992
Hall JE, Brands MW. The Renin-Angiotensin-Aldosterone System: Renal Mechanisms and Circulatory Homeostasis. In: The Kidney: Physiology and Pathophysiology, 2nd Edition Eds. D.W. Seldin and G. Giebisch. Raven Press, New York, 1992. p 1455-15041992
Hall JE, Guyton AC. Control of Sodium Excretion and Arterial Pressure by Intrarenal Mechanisms and the Renin-Angiotensin System. In: Hypertension: Pathophysiology, Diagnosis and Management Eds. J.H. Laragh, B.M. Brenner. Raven Press Ltd., New York, 1990. p 1105-11301990
Guyton AC, Hall JE, Coleman TG, Manning Jr. RD. The Dominant Role of the Kidneys in the Long-Term Regulation of Arterial Pressure in Normal and Hypertensive States. In: Hypertension: Pathophysiology. Diagnosis and Management. Eds. J.H. Laragh and B.M. Brenner. Raven Press Ltd., New York, 1990. p 1029-10521990
Hall JE. Angiotensin Converting Enzyme Inhibition: Renal Effects and Their Role in Reducing Arterial Pressure. In: Current Advances in ACE Inhibitions Eds. G.A. McGregor and P. Sever. Churchill Livingston, London, 1989. pp 9-241989
Hall JE, Montani JP, Woods LL, Mizelle HL. Role of vasopressin and pressure diuresis in regulation of arterial pressure and body fluid volumes. Vasopressin, cellular and integrative functions Eds. A.W. Cowley Jr, J.F. Liard, D.A. Ausiello. Raven Press, New York, 1988. pp. 193-2001988
Hall JE, Guyton AC, Coleman TG, Woods LL, Mizelle HL. Renal excretory function and hypertension. In: Perspectives in hypertension, Vol 1, The kidney in hypertension. Eds. B.M. Brenner and J.H. Laragh. Raven Press, New York, 1987. pp. 1-20.1987
Petrini MF, Coleman TG, Hall JE. Basic Quantitative Concepts of Lung Function. The Lung. In: Mathematical Methods in Medicine, Part 2 Eds. D. Ingram and R. Bloch. John Wiley and Sons, New York, 1986. pp 295-3361986
Coleman TG, Hall JE, Petrini MF. Basic Quantitative Concepts of the Circulating System. The Circulation. In: Mathematical Methods in Medicine, Part 2 Eds. D. Ingram, R. Bloch. John Wiley and Sons, New York, 1986. pp 175-1951986
Hall JE. Role of Angiotensin and Aldosterone in Volume Homeostasis. In: Body Fluid Homeostasis. Contemporary Issues in Nephrology, Vol. 17 Eds. B.M. Brenner and J.H. Stein. Churchill Livingston, New York, 1986. p 69-1001986
Hall JE, Coleman TG, Petrini MF. The Kidney. In: Mathematical Methods in Medicine, Part . Eds. D. Ingram and R. Bloch. Wiley Publishing Co., Ed. D. Ingram and R. Bloch. John Wiley and Sons, New York, 1986. pp. 427-4711986
Hall JE, Montani JP. Role of the Kidney in Adrenocortical Induced Hypertension. In: The Adrenal Gland and Hypertension Eds. F. Mantero, E.G. Biglieri, J.W. Funder, B.A. Scoggins. Rave Press, New York, 1985, pp 185-2081985
Guyton AC, Lohmeier TE, Hall JE, Smith MJ, Kastner PR. The Infinite Gain Principle for Arterial Pressure Control by the Kidney-Volume-Pressure System. In: Fundamental Fault in Hypertension Ed. M.P. Samishi. Martinus Nijhoff Publishers, Boston, 1984. p. 35-611984
Guyton AC, Manning RD, Lohmeier TE, Hall JE. The Kidney and Hypertension. In: Dopamine Receptor Agonists Ed. F.H. Messerli. Martinus Nijhoff Publishing, Boston, 1984. p. 87-1031984
Guyton AC, Hall JE, Lohmeier TE, Manning Jr RD, Jackson TE, Kastner PR, Pan YJ. Role of the Kidney and Volume Control in the Pathogenesis of Hypertension. In: Handbook of Hypertension. Eds. W.H. Birkenhager and J.L. Reid. Vol. 1: Clinical Aspects of Essential Hypertension. Ed. J.I.S. Robertson. Elsevier, Amsterdam, 1983. pp. 216-238.1983
Young DB, Pan Y, Hall JE, Lohmeier TE. Importance of Antinatriuretic Eeffects of Angiotensin and Aldosterone in Hypertension. In: Salt and Cardiovascular Hypertension Eds. M.J. Fregley and M.R. Kare. Academic Press, Philadelphia, 1982. pp. 247-2651982
Hall JE. Regulation of Renal Hemodynamics. In: International Review of Physiology. Cardiovascular Physiology IV, Volume 26 Ed. A.C. Guyton and J.E. Hall. University Park Press, Baltimore, 1982. pp. 243-3211982
Coleman TG, Hall JE, Norman Jr. RA. Regulation of Arterial Blood Pressure. In: Hypertension. Contemporary Issues in Nephrology. Vol. 8 Eds. B.M. Brenner and J.H. Stein. Churchill Livingston, New York, 1981. pp. 1-201981
Guyton AC, Hall JE, Lohmeier TE, Manning Jr RD, Jackson TE. The Concept of Whole Body Autoregulation and the Dominant Role of the Kidneys for Long-Term Blood Pressure Regulation. In: Frontiers in Hypertension Research Eds. J.H. Laragh, F.R. Buhler, D.W. Seldin. Springer-Verlag, New York, 1981. p 125-1341981
Coleman TG, Manning RD, Norman Jr. RA, Samar RE, Hall JE, Guyton AC. Experimental Renoprival Hypertension. In: Hemodynamics of Arterial Hypertension Eds. C.M. Ferrario, M.N. Levy, R.C. Tarazi, C.V. Mosby. 19801980
Hall JE, Jackson TE, Guyton AC. Feedback Control of Intrarenal Function by the Renin-Angiotensin System. In: Arterial Pressure and Hypertension Eds. A.C. Guyton. W.B. Saunders Co., 1980. p 192-2041980
Guyton AC, Hall JE, Norman Jr RA, Smith JR MJ, Balfe JW, Kastner PR. Physiology of Blood Pressure Regulation. In: Childhood Prevention of Atherosclerosis and Hypertension Eds. R.M. Lauer, R.B. Shekelle. Raven Press, New York, 1980. pp. 251-2621980
Guyton AC, Hall JE, Lohmeier TE, Jackson TE. Modern Concepts of Circulatory Function. In Cardiology (International Congress Series 470) Eds. S. Hayase, S. Murao. Excerpta Medica, Amsterdam, 1979. pp.60-681979
Guyton AC, Hall JE, Manning Jr RD, Norman Jr RA, DeClue JW. A Systems Analysis of Volume Regulation. In Alfred Benzon Symposium XI, Osmotic and Volume Regulation. Munksgaard, Copenhagen, 1978 pp 283-2961978
Guyton AC, Cowley Jr. AW, Young DB, Coleman TG, Hall JE, DeClue JW. Integration and control of circulatory function In: International Review of Physiology. Cardiovascular Physiology II. Eds. A.C. Guyton and A.W. Cowley Jr. University Park Press, Baltimore, 1976. pp 341-3851976
Guyton AC, Young DB, DeClue JW, Ferguson JD, McCaa RE, Cevese A, Trippodo NC, Hall JE. The Role of the Kidney in Hypertension In: Pathophysiology and Management of Arterial Hypertension. Eds. G. Berglund, L. Hansoon, and L. Werko. A. Lindgren and Soner A.B., Molndal, Sweden, 1975. pp 78-891975

Book

Hall, JE Guyton and Hall Textbook of Medical Physiology, 13th Edition Elsevier Saunders, Philadelphia, 20162016
Hall, JE Guyton and Hall Physiology Review, 3rd edition Elsevier Saunders, Philadelphia, 20162016
Hall, JE Pocket Companion for Guyton and Hall Textbook of Medical Physiology Elsevier Saunders, Philadelphia, 5th Edition, 20162016
Hall JE Guyton and Hall Physiology Review, 2nd edition Elsevier Saunders, Philadelphia, 20112011
Hall JE Pocket Companion for Guyton and Hall Textbook of Medical Physiology Elsevier Saunders, Philadelphia, 4th Edition, 20112011
Hall, JE Guyton and Hall Textbook of Medical Physiology, 12th Edition Elsevier Saunders, Philadelphia, 20112011
Lip GYP, Hall JE (eds.). Comprehensive Hypertension Elsevier, New York, 20072007
Hall JE. Guyton and Hall Physiology Review Elsevier Saunders, Philadelphia, 20062006
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall Elsevier Saunders, Philadelphia, 3rd Edition, 20062006
Guyton AC, Hall JE (ed.). Textbook of Medical Physiology, 11th Edition Elsevier Saunders, Philadelphia, 20062006
Hall JE, Adair TH. Rypins' Questions and Answers for Basic Sciences Review - Physiology, 4th Ed., ed. E.D. Frohlich J.B.Lippincott Co., Philadelphia, 20012001
Hall JE, Adair TH. Rypins’ Basic Sciences Review - Physiology, 18th Ed., ed. E.D. Frohlich J.B. Lippincott Co., Philadelphia, 20012001
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall, 2nd edition W.B. Saunders Co., Philadelphia, 20002000
Guyton AC, Hall JE. Textbook of Medical Physiology, 10th Edition W. B. Saunders Co., Philadelphia, 20002000
Guyton AC, Hall JE. Human Physiology and Mechanisms of Disease, 6th Edition W.B. Saunders Co., Philadelphia, 19971997
Hall JE, Adair TH. Physiology. Rypins’ Intensive Reviews Lippincott - Raven, Philadelphia, 19971997
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall W.B. Saunders Co., Philadelphia, 19971997
Hall JE, Adair TH. Rypins’ Basic Sciences Review - Physiology, 17th Ed., ed. E.D. Frohlich J.B. Lippincott Co., Philadelphia, 19971997
Hall JE, Adair TH. Rypins’ Questions and Answers for Basic Sciences Review - Physiology, 3rd Ed., ed. E.D. Frohlich J.B.Lippincott Co., Philadelphia, 19971997
Guyton AC, Hall JE. Textbook of Medical Physiology, 9th Edition W.B. Saunders Co., Philadelphia, 19961996
Guyton AC, Hall JE. Cardiovascular Physiology IV, International Review of Physiology University Park Press, Baltimore, 19821982

Editorial Commentary

Jones DW, Hall JE. JNC-7 and evidence from new hypertension trials Hypertension. 2004; 43:1-32003
Hall JE. The renin-angiotensin system and control of renal function: historical perspective In: One Hundred Years of the Renin-Angiotensin System: Past Accomplishments and Future Prospects. Ed. M.G. Nichols., H.R. Brunner, H. Ikram, C.S. Sweet, and J.F. Walker. p.21-26, 19981998
Hall JE. Speculation on regulatory, integrative and comparative physiology (the Journal) Am J Physiol. 1996; 270:R1-R21996
Brands MW, Hall JE. Hyperinsulinemia and hypertension Nutr Metab Cardiovasc Dis. 1994; 3:155-1571994

Letter to the Editor

Pickering TG. Hall JE, Appel L, Falkner B, Graves J, Hill M, Jones DW, Kurtz T, Sheps S, Roccella E. Response to recommendations for blood pressure measurement in human and experimental animals; Part 1: Blood pressure measurement in humans and miscuffing: A problem with new guidelines Hypertension. 2006; 48:e5-e62006
Skek EW, Hall JE, Brands MW. Leptin and the renin-angiotensin-aldosterone system Hypertension. 1998; 32:3761998

Historical Article

Hall JE, The kidney, hypertension, and obesity. Hypertension (Dallas, Tex. : 1979), 2003 Mar;41(3 Pt 2):625-332003
Hall JE, Historical perspective of the renin-angiotensin system. Molecular biotechnology, 2003 May;24(1):27-392003

Comment

Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE, AHA Council on High Blood Pressure Research, Professional and Public Education Subcommittee, Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arteriosclerosis, thrombosis, and vascular biology, 2005 Mar;25(3):478-92005
Jones DW, Hall JE, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension (Dallas, Tex. : 1979), 2004 Jan;43(1):1-32004
Jones DW, Hall JE, The national high blood pressure education program: thirty years and counting. Hypertension (Dallas, Tex. : 1979), 2002 May;39(5):941-22002
Hall JE, Jones DW, What can we do about the "epidemic" of obesity. American journal of hypertension, 2002 Jul;15(7 Pt 1):657-92002
Hall JE, The promise of translational physiology. American journal of physiology. Cell physiology, 2001 Nov;281(5):C1411-22001

Editorial

Mancia G, Hall JE, Introduction to a Compendium on the Pathophysiology and Treatment of Hypertension. Circulation research, 2019 Mar 29;124(7):967-9682019
Hall JE, Hall ME, Cardiometabolic Surgery for Treatment of Hypertension? Hypertension (Dallas, Tex. : 1979), 2019 Mar;73(3):543-5462019
Hall JE, Thirtieth anniversary of Hypertension: evolution of a journal and a progress report. Hypertension (Dallas, Tex. : 1979), 2009 Oct;54(4):685-82009
Jones DW, Hall JE, Hypertension: pathways to success. Hypertension (Dallas, Tex. : 1979), 2008 May;51(5):1249-512008
Hall JE, Hypertension: update 2008. Hypertension (Dallas, Tex. : 1979), 2008 Sep;52(3):425-82008
Jones DW, Hall JE, World Hypertension Day 2007. Hypertension (Dallas, Tex. : 1979), 2007 May;49(5):939-402007
Jones DW, Hall JE, Racial and ethnic differences in blood pressure: biology and sociology. Circulation, 2006 Dec 19;114(25):2757-92006
Hall JE, The pioneering use of systems analysis to study cardiac output regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2004 Nov;287(5):R1009-112004
Hall JE, The promise of translational physiology. Journal of neurophysiology, 2003 Feb;89(2):646-72003

Presentations

National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity and Metabolic Syndrome, First Caribbean Obesity Summit: Diabetes & Obesity; Second Scientific Meeting of the American Physiological Society, Puerto Rico Chapter, Ponce, Puerto Rico03/2012
Invited Symposia, Hypertension From Bench to Bedside: A Tale of Mice and Men, André Aisenstadt Memorial Clinical Day, Jewish General Hospital, Montreal, Canada10/2011
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Physiology of Cardiovascular Disease: Gender Disparities, American Physiological Society, Jackson, MS10/2011
National and International Invited Seminars/Lectures, Central Role of Obesity in Hypertension and Cardiometabolic Disease, American Heart Association Council for High Blood Pressure Research, Orlando, FL09/2011
Invited Symposia, 38th Annual Pharmacology Research Colloquium and the Department of Physiology and Pharmacology 2nd Students Research Forum, University of Toledo Health Sciences Campus, Toledo, OH06/2011
National and International Invited Seminars/Lectures, Role of Aldosterone and Mineralocorticoid Receptor Activation in Obesity Related Hypertension, American Society of Hypertension, New York, NY05/2011
National and International Invited Seminars/Lectures, Obesity-Related Hypertension: Basic Concepts and Clinical Implications, American Society of Hypertension, New York, NY05/2011
National and International Invited Seminars/Lectures, Hypertension in Obesity/Metabolic Syndrome: Basic Concepts and Clinical Implications, Yangtze River International Congress of Cardiology, Chongqing City, China04/2011
National and International Invited Seminars/Lectures, Mechanisms of Salt-Sensitive Hypertension and Target Organ Injury, Yantze River International Congress of Cardiology, Chongqing City, China04/2011
Visiting Professor, Visiting Professor, Third Medical University, Chongqing City, China04/2011
Invited Symposia, Leptin, obesity and hypertension: Understanding the key mechanisms, International Society of Nephrology, Vancouver, British Columbia, Canada04/2011
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Indiana Physiological Society Meeting, Indianapolis, Indiana02/2011
Scientific Presentations, Methodological Issues in Collecting Urinary Sodium in NHANES, National Heart, Lung and Blood Institute, Bethesda, MD01/2011
Invited Symposia, Obesity – A Growing Threat to our Health & Economy, Singing River Health System, Biloxi, MS11/2010
National and International Invited Seminars/Lectures, Obesity Hpertension and Renal Hemodynamics, FASEB Summer Research Conference on "Renal Hemodynamics: Mechanisms to Understand Disease, Saxton River, VT06/2010
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, University of Alberta Cardiovascular Centre, Edmonton, Canada06/2010
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, University of Missouri-Columbia, Columbia, Missouri05/2010
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Department of Physiology and Pharmacology, Department of Medicine Grands Rounds,University of Toledo College of Medicine, Toledo, Ohio05/2010
Invited Symposia, Renal Function and the Law of Starling, Symposium on “One Hundred Years of Starling: his Contributions to Physiology", Experimental Biology 2010, American Physiological Society, Anaheim, California04/2010
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Hypertension Symposium, Boston University School of Medicine, Boston, MA04/2010
Scientific Presentations, Pathophysiology of Obesity Hypertension, Merck & Co, Cardiovascular Diseases Division, Rahway, NJ10/2009
National and International Invited Seminars/Lectures, Pathophysiology of Obesity/Metabolic Syndrome, Michigan State University, Department of Toxicology, East Lansing, MI10/2009
Scientific Presentations, Session on “Meet the Expert”, XV Scientific Sessions of the Inter-American Society of Hytpertension, Inter-American Society of hypertension, Belo Horizonte, Brazil08/2009
National and International Invited Seminars/Lectures, Plenary lecture, XV Scientific Sessions of the Inter-American Society of Hytpertension-"Hypertension and Obesity", Inter-American Society of Hypertension, Belo Horizonte, Brazil08/2009
National and International Invited Seminars/Lectures, Meet the Expert Session on Obesity Hytension-
What the Hypertension Specialist Know about
Experimental Hypertension and Obesity, American Society of Hypertension, San Francisco, CA
05/2009
National and International Invited Seminars/Lectures, Pathobiology of Obesity- What the Hypertension Specialist know about Experimental Hypertension and Obesity, American Society of Hypertension, San Francisco, CA05/2009
Invited Symposia, Pathophysiology of hypertension in obesity/metabolic syndrome, University of Arkansas Medical School, Department of Pharmacology and Toxicology, Little Rock, AR04/2009
National and International Invited Seminars/Lectures, Pathophysiology of hypertension in obesity/metabolic syndrome, University of Utah, Department of Medicine, Division of Nephrology, Salt Lake City, Utah04/2009
National and International Invited Seminars/Lectures, Hypothalamic melanocortins, sympathetic activation, and obesity hypertension, Palatin Technologies, Inc, Princeton, New Jersey02/2009
Invited Symposia, Invited Speaker, Medical Student Research Day, Medical Student Research Day, University of Alabama-Birmingham, Birmingham, Alabama11/2008
Regional Invited Seminars/Lectures, Pathophysiology of hypertension in obesity/metabolic syndrome: Role of adipokines, Department of Physiology & Biophysics, University of Alabama-Birmingham, Birmingham, AL11/2008
National and International Invited Seminars/Lectures, Obesity, Hypertension and Renal Hemodynamics, International Society of Nephrology Nexus Symposium, Diabetes and the Kidney, Dublin, Ireland06/2008
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Department of Medicine, University of Texas Health Science Center, San Antonio, TX05/2008
Invited Symposia, The Kidney: Aging, Apoptosis, Endocrine Sensitivity and the Kidney’s Role in Hypertension, Experimental Biology 2008, San Diego, CA04/2008
National and International Invited Seminars/Lectures, Hypertension and the Kidney, International Society of Nephrology Nexus Symposium, Hypertension and the Kidney, Vienna, Austria11/2007
National and International Invited Seminars/Lectures, Mechanisms of Hypertension in Obesity/Metabolic Syndrome, Canadian Hypertension Society 28th Annual Meeting, Quebec City, Canada10/2007
Invited Symposia, Pathophysiology of hypertension in obesity/metabolic syndrome, Department of Physiology, University of Maryland, Baltimore, MD05/2007
National and International Invited Seminars/Lectures, Obesity, Adipokines and Hypertension, 17th Meeting of Inter-American Society of Hypertension, Miami, FL05/2007
Invited Symposia, Invited Lecture, Clinical Nutrition Research Center, University of Alabama-Birmingham, Birmingham, AL03/2007
Invited Symposia, CVI Seminar, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA02/2007
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Tulane University School of Medicine, New Orleans, LA11/2006
Meet the Professor, Cardiovascular Complications of Obesity, 3rd Endocrinology Canada International Symposium, Toronto, Canada11/2006
Invited Symposia, Pathology of Hypertension in Obesity/Metabolic Syndrome, 3rd Endocrinology Canada International Symposium, Toronto, Canada11/2006
Invited Symposia, Pathophysiology of Obesity Hypertension: Neurohumoral and Renal Mechanisms, Department of Medicine, Nephrology Grand Rounds, University of Virginia, Charlottesville, VA11/2006
Invited Symposia, Distinguished Lecturer, Department of Physiology, Anatomy and Genetics, Oxford University, Oxford, England, United Kingdom11/2006
National and International Invited Seminars/Lectures, Role of the Renin-Angiotensin Aldosterone System, Keynote Lecture at International Symposium, Sendai, Japan10/2006
National and International Invited Seminars/Lectures, Salt, Kidney and Hypertension, Keynote Lecture at International Symposium, Nagoya, Japan10/2006
National and International Invited Seminars/Lectures, Adipokines, Obesity and Hypertension, International Society of Hypertension, Fukuoka, Japan10/2006
Invited Symposia, Invited Professor-"Pathophysiology of Hypertension in
Obesity/Metabolic Syndrome", Nephrology Division and Department of Physiology, University of Florida, Gainesville, FL
08/2006
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Merck & Co., Cardiovascular Diseases Division, Rahway, NJ06/2006
National and International Invited Seminars/Lectures, Obesity and Hypertension: Role of the renin-angiotensin- aldosterone system, Novartis Institutes for Biomedical Research, East Hanover, NJ06/2006
Invited Symposia, Nephrology and Hypertension Grand Rounds-"Metabolic Syndrome, Hypertension, and Cardiovascular-Renal Disease", Mayo Clinic College of Medicine, Rochester, MN04/2006
Invited Symposia, Research Forum-Neurohumoral and Renal Mechanisms of Obesity Hypertension, Mayo Clinic College of Medicine, Rochester, MN04/2006
Scientific Presentations, Obesity and Renal Disease, Experimental Biology 2006, San Francisco, CA04/2006
Scientific Presentations, Melanocyte Stimulating Hormones and Their Receptors, Experimental Biology 2006, San Francisco, CA04/2006
Scientific Presentations, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Eli Lilly Research Laboratories “Endocrine Think Tank”, Indianapolis, IN11/2005
Invited Symposia, Invited Lecture, Georgetown University Medical Center, Cardiovascular-Kidney Institute, Washington, DC10/2005
National and International Invited Seminars/Lectures, Obesity and metabolic syndrome, Inter-American Society of Hypertension Symposium, Cancun, Mexico04/2005
Invited Symposia, Vascular regulatory abnormalities in obesity, Microcirculatory Society's President's Symposium, San Diego, California04/2005
Invited Symposia, Hypertension and metabolic syndrome, Pfizer, St. Louis, Missouri01/2005
State/Local Invited Seminars/Lectures, A. Ross McIntyre Memorial Lecture, University of Nebraska Medical Center, Omaha, Nebraska2005
National and International Invited Seminars/Lectures, Hypertension Summer School, American Heart Association, Castine, Maine2005
Regional Invited Seminars/Lectures, Keynote Speaker at Regional Hypertension Workshop, Kellogg Biological Station, Michigan2005
National and International Invited Seminars/Lectures, Workshop on "Emerging Concepts on Neural Intractions in Hypertension", American Heart Association, Council for High Blood Pressure Research, Washington, D.C.2005
Invited Symposia, Renal mechanisms of salt sensitive hypertension, American Society of Hypertension, New York, NY05/2004
National and International Invited Seminars/Lectures, Mechanisms of obesity hypertension, 20th Scientific Meeting of the International Society of Hypertension, Sao Paulo, Brazil02/2004
Invited Symposia, Arthur C. Guyton: the Man and His Science, Experimental Biology, Washington, D.C.2004
Invited Symposia, Cardiovascular Injury and the Renin-Angiotensin System, Takeda Pharmaceuticals, New Orleans, Louisiana2004
Visiting Professor, Invited Lecture, Eastern Virginia Medical School, Department of Physiology2004
State/Local Invited Seminars/Lectures, Invited Lecture, Pfizer Global Research & Development, St. Louis, Missouri2004
State/Local Invited Seminars/Lectures, Invited Lecture, Louisiana State University, Department of Physiology, New Orleans, Louisiana2004
Visiting Professor, Invited Lecture, Medical College of Georgia, Deparment of Physiology, Augusta, Georgia2004
National and International Invited Seminars/Lectures, Keynote Lecture, The Society of Nephrology and Hypertension of Puerto Rico, San Juan, Puerto Rico2004
National and International Invited Seminars/Lectures, Keynote Lecture, The 4th Annual Meeting of The Safety Pharmacology Society, Cincinnati, Ohio2004
State/Local Invited Seminars/Lectures, Medicine Grand Rounds Lecture at "E. Eric Muirhead Hypertension Research Day", The University of Tennessee Health Sciences Center, Memphis, Tennessee2004
National and International Invited Seminars/Lectures, Renal Microcirculatory and Tubular Dynamics: Molecules to Man, FASEB Summer Conference, Pine Mountain, Georgia2004
State/Local Invited Seminars/Lectures, Invited Lecture, Merck, Sharpe & Dohme Obesity Research Group, Rahway, New Jersey2003
Visiting Professor, Invited Lecture, Wake Forest University, Bowman Gray School of Medicine, Hypertension and Vascular Disease Center, Winston Salem, North Carolina2003
National and International Invited Seminars/Lectures, Invited Lecture, 5th European Federation of Autonomic Societies Meeting, Toulouse, France2003
National and International Invited Seminars/Lectures, Invited Lecture, International Conference on Mediterranean Cardiovascular Risk, Murcia, Spain2003
State/Local Invited Seminars/Lectures, Invited Lecture, Medical College of Wisconsin, Department of Physiology2003
Invited Symposia, New Frontiers in Cardiovascular Disease Management, San Antonio, Texas2003
Regional Invited Seminars/Lectures, Plenary Session on "Syndrome X- Fact or Fiction", Southern Society for Clinical Investigation, New Orleans, Louisiana2003
National and International Invited Seminars/Lectures, Symposium in honor of Arthur C. Guyton, Biomedical Engineering Society, Nashville, Tennessee2003
State/Local Invited Seminars/Lectures, Symposium on "Obesity: Complications and Treatment", University of Houston, Heart and Kidney Institute2003
Invited Symposia, The Last 10 Years in Cardiovascular Disease Management, Wake Forest University School of Medicine, Winston Salem, North Carolina2003
National and International Invited Seminars/Lectures, Workshop on "The Insulin Resistance Syndrome and the Pathophysiology of Hypertension, Cardiovascular and Renal Disease", Council for High Blood Pressure Research Workshop, Washington, D.C.2003
National and International Invited Seminars/Lectures, Conference Magna Lecture on "Obesity, Hypertension and Kidney Disease- the Last Frontier of Prevention", Brazilian Society of Hypertension, Porto Alegre, Brazil2002
National and International Invited Seminars/Lectures, Hypertension and the Plurimetabolic Syndrome, Brazilian Society of Hypertension, Porto Alegre, Brazil2002
State/Local Invited Seminars/Lectures, Keynote Lecture, Hypertension and Related Disorders Meeting, Sydney, Australia2002
State/Local Invited Seminars/Lectures, Mechanisms of Hypertension and Renal Disease in the Metabolic Syndrome, GlaxoSmith Kline Pharmaceuticals Co., Philadelphia, Pennsylvania2002
State/Local Invited Seminars/Lectures, Medical Grand Rounds, University of Puerto Rico School of Medicine, San Juan, Puerto Rico2002
State/Local Invited Seminars/Lectures, Medical Grand Rounds, Veterans Administration Hospital, University of Puerto Rico School of Medicine, San Juan, Puerto Rico2002
Visiting Professor, Nephrology Grand Rounds, Thomas Jefferson Medical College, Philadelphia, Pennsylvania2002
National and International Invited Seminars/Lectures, Novartis Award Lecture, American Heart Association, Council for High Blood Pressure Research2002
National and International Invited Seminars/Lectures, Obesity, Hypertension and Kidney Disease, Kyushu University, Fukuoka, Japan2002
National and International Invited Seminars/Lectures, Physiological Approach to Hypertension Research: Role of the Kidney, 25th Meeting of Japanese Society of Hypertension, Tokyo, Japan2002
National and International Invited Seminars/Lectures, Symposium on "Blood Pressure Control in Cardiovascular Disease Prevention", Japanese Society of Hypertension, Tokyo, Japan2002
National and International Invited Seminars/Lectures, Symposium on "Hypertension and Diabetes: The Emerging Epidemic", American Heart Association, 75th Scientific Sessions, Chicago, Illinois2002
National and International Invited Seminars/Lectures, Symposium on "Obesity and Cardiovascular Disease", American Heart Association, 75th Scientific Sessions, Chicago, Illinois2002
National and International Invited Seminars/Lectures, The Metabolic Syndrome and Hypertension: The Next Frontier of Prevention and Treatment of Cardiovascular Disease, Tokyo Medical University, Tokyo, Japan2002
Invited Symposia, Vascular Biology and Hypertension Research Symposium, Destin, Florida2002
National and International Invited Seminars/Lectures, Experimental Models of Obesity and Hypertension, XIV Meeting of the Inter-American Society of Hypertension, Santiago, Chile2001
Visiting Professor, Invited Lecture, Indiana University School of Medicine, Indianapolis, Indiana2001
Burroughs Wellcome Visiting Professor, Invited Lecture, University of North Dakota School of Medicine, Vermillion, North Dakota2001
Visiting Professor, Invited Lecture, University of North Carolina, Department of Cell and Molecular Physiology, Chapel Hill, North Carolina2001
Visiting Professor, Invited Lecture, Department of Internal Medicine and Cardiovascular Research Institute, University of North Dakota, Sioux Falls, North Dakota2001
Visiting Professor, Invited Lecture, University of Kentucky, School of Pharmacy and School of Medicine2001
National and International Invited Seminars/Lectures, Invited Lecture, International Society of Obesity Hypertension, Berlin, Germany2001
National and International Invited Seminars/Lectures, Obesity , the Renin-Angiotensin System, and Renal Damage in the Hypertensive Patient, Spanish Hypertension Society, Malaga, Spain2001
National and International Invited Seminars/Lectures, Role of Leptin and Sympathetic Nervous System in Hypertension, International Pediatric Hypertension Association, San Francisco, California2001
Regional Invited Seminars/Lectures, Symposium on "Obesity-Associated Hypertension: Pathophysiology and Treatment", Consortium for Southeastern Hypertension Control, Charleston, South Carolina2001
National and International Invited Seminars/Lectures, Vertical Integration of Physiology in the Medical School Curriculum, Association of Charis of Departments of Physiology, Los Cabos, Mexico2001
National and International Invited Seminars/Lectures, Workshop on the "Pathophysiology of Obesity- Associated Cardiovascular Disease", National Heart, Lung and Blood Institute, Bethesda, Maryland2001
Regional Invited Seminars/Lectures, Hypertension and Cardiovascular Disease in ESRD, Southeastern Dialysis and Transplantation Association, Biloxi, Mississippi2000
National and International Invited Seminars/Lectures, Hypertension and the New Biology of Obesity, 1st John H. Laragh Conference on Advances in Hypertension Research, Boca Raton, Florida2000
Visiting Professor, Invited Lecture, Louisiana State University Medical Center, Shreveport, Louisiana2000
Visiting Professor, Invited Lecture, Georgetown University Medical Center, Washington, D.C.2000
Visiting Professor, Invited Lecture, University of Houston, Department of Physiology and Pharmaceutical Sciences, Houston, Texas2000
National and International Invited Seminars/Lectures, Mechanisms of Obesity Hypertension and Renal Disease, Cardiovascular Research Division, Searle Pharmaceuticals, St. Louis, Missouri2000
National and International Invited Seminars/Lectures, Obesity Hypertension, Spanish Society of Hypertension, Madrid, Spain2000
National and International Invited Seminars/Lectures, Richard Bright Award Lecture on "Obesity, Hypertension, and Kidney Disease", 15th Scientific Meeting of the American Society of Hypertension, New York, New York2000
National and International Invited Seminars/Lectures, State of the Art Lecture on "Mechanisms of Obesity Hypertension and Relevance to Essential Hypertension", International Society of Hypertension, Chicago, Illinois2000
National and International Invited Seminars/Lectures, Basic Science Review of Salt Intake and Cardiovascular Disease, American Society of Hypertension, New York, New York1999
State/Local Invited Seminars/Lectures, Distinguished Lecturer, Hypertension Research Center, University of Medicine and Dentistry of New Jersey, Newark, New Jersey1999
National and International Invited Seminars/Lectures, Integration and Regulation of Cardiovascular Function, The APS, Experimental Biology, Washington, D.C.1999
Visiting Professor, Invited Lecture, Colorado State University, Ft. Collins, Colorado1999
Visiting Professor, Invited Lecture, University of Alabama- Birmingham School of Medicine, Department of Physiology1999
National and International Invited Seminars/Lectures, Mechanisms of Obesity-Related Hypertension, Local vs. Circulating Angiotensin II: Are They Both Involved in Hypertension?, AHA, Third Hypertension Summer School, Boulder, Colorado1999
National and International Invited Seminars/Lectures, Obesity, Hypertension, and End-Stage Renal Disease, XIIIth Meeting of Inter-American Society of Hypertension, Buenos Aires, Argentina1999
National and International Invited Seminars/Lectures, Obesity: Impact on Cardiovascular Disease, American College of Cardiology, 48th Annual Sessions, New Orleans, Louisiana1999
National and International Invited Seminars/Lectures, Renal Mechanisms of Obesity Hypertension, International Symposium on Obesity and Hypertension, Berlin, Germany1999
National and International Invited Seminars/Lectures, Role of Neuropeptides and the Sympathetic Nervous System in Obesity Hypertension, III International Symposium on Vasoactive Peptides, Belo Horizonte, Brazil1999
National and International Invited Seminars/Lectures, Role of Obesity in Hypertension and End-Stage Renal Disease, Congresso da Sociedade Brasileira de Hipertensao, Rio de Janeiro, Brazil1999
National and International Invited Seminars/Lectures, The Metabolic Syndrome X: Convergence of Insulin Resistance, Hypertension, Obesity, and Dyslipidemias, New York Academy of Sciences, Jacksonville, Florida1999
Workshop, Workshop on Sodium and Blood Pressure, National Heart, Lung, and Blood Institute, Bethesda, Maryland1999
National and International Invited Seminars/Lectures, 100 Years of the Renin-Angiotensin System: Past Accomplishments and Future Prospects, International Symposium, Rome, Italy1998
National and International Invited Seminars/Lectures, Angiotensin Receptor Blockade and the Kidney, American Society of Nephrology, Philadelphia, Pennsylvania1998
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, VII Congress of Brazilian Society of Hypertension, Goiania, Brazil1998
National and International Invited Seminars/Lectures, Ernest G. Starling Distinguished Lecture, The American Physiological Society, Experimental Biology, San Francisco, California1998
Visiting Professor, Invited Lecture, Rush-Presbyterian- St. Luke's Medical Center, Rush University, Chicago, Illinois1998
Visiting Professor, Invited Lecture, Heart Institute, Universidade de Sao Paulo, Brazil1998
Visiting Professor, Invited Lecture, Physiology Department, Faculdade de Medicina de Ribeiro Preto, Da Universidade de Sao Paulo, Brazil1998
Visiting Scientist, Invited Lecture, Merck, Sharp and Dohme Research Laboratories, West Point, Pennsylvania1998
National and International Invited Seminars/Lectures, Is Obesity the Culprit in Causing Excess Hypertension and End-Stage Renal Disease in African-Americans?, Third Congress on Treatment of Cardiovascular Diseases in African-Americans, Dallas, Texas1998
State/Local Invited Seminars/Lectures, Keynote Lecture, 75th Anniversary of Physiology Department, Michigan State University, East Lansing, Michigan1998
National and International Invited Seminars/Lectures, Keynote Lecture, 4th Meeting on the Kidney and Hypertension, Tokyo, Japan1998
National and International Invited Seminars/Lectures, Mechanisms of Renal Dysfunction in Obesity and Role in Hypertension, American Society of Hypertension, New York, New York1998
State/Local Invited Seminars/Lectures, Obesity and Hypertension, Mississippi Academy of Sciences1998
National and International Invited Seminars/Lectures, Obesity: Impact on Cardiovascular Disease, American Heart Association, Amelia Island, Florida1998
State/Local Invited Seminars/Lectures, Pfizer Lecture, Clinical Research Institute of Montreal, Montreal, Canada1998
National and International Invited Seminars/Lectures, Salt, Hypertension and the Pathophysiology of Cardiovascular Disease, University of Tokyo, Tokyo, Japan1998
National and International Invited Seminars/Lectures, Sodium: To Restrict or Not to Restrict For the Hypertensive Patient, 7th Annual National Kidney Foundation Meeting, Nashville, Tennessee1998
State/Local Invited Seminars/Lectures, Why Is There So Much Cardiovascular Disease in Mississippi, Tougaloo College, Jackson, Mississippi1998
National and International Invited Seminars/Lectures, Abnormal Kidney Function as a Cause and Consequence of Obesity Hypertension, Experimental Biology, New Orleans, Louisiana1997
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, American Society of Hypertension, San Francisco, California1997
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, and Relevance to Essential Hypertension, Astra-Hassle, Gothenberg, Sweden1997
National and International Invited Seminars/Lectures, Insulin Resistance and Obesity, and Their Role in Cardiovascular and Renal Disease, American Society of Nephrology, Clinical Sciences Symposium, San Antonio, Texas1997
National and International Invited Seminars/Lectures, Intrarenal Actions of Angiotensin II and Long-Term Blood Pressure Regulation, International Centenary Symposium in Honor of Robert Tigerstedt, Stockholm, Sweden1997
Visiting Professor, Invited Lecture, Hypertension Center, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina1997
National and International Invited Seminars/Lectures, Obesity, Insulin Resistance and Cardiovascular Disease, International Symposium on Hypertension, Seville, Spain1997
National and International Invited Seminars/Lectures, Renal Mechanism of Obesity Hypertension and Relevance to Essential Hypertension, XXXIII International Congress of Physiological Sciences, St. Petersburg, Russia1997
National and International Invited Seminars/Lectures, Resistance to Metabolic Actions of Insulin and Cardiovascular Disease, Inter-American Society of Hypertension, Mexico City, Mexico1997
National and International Invited Seminars/Lectures, Salt-Sensitivie Hypertension and Vascular Disease, International Symposium on Hypertension, Seville, Spain1997
National and International Invited Seminars/Lectures, Advances in the Genetics and Therapy of Obesity: Cardiovascular Implications, American Heart Association Annual Meeting1996
National and International Invited Seminars/Lectures, Insulin Resistance and its Role in Cardiovascular Disease, Fourth Congress of Argentine Society of Hypertension, Buenos Aires, Argentina1996
National and International Invited Seminars/Lectures, Resistance to Metabolic Actions of Insulin and Hypertension, Hypertension Society of Mexico, Mexico City, Mexico1996
Regional Invited Seminars/Lectures, Salt, Vascular Injury, and Hypertension, Consortium of Southeastern Hypertension Centers, Raleigh, North Carolina1996
National and International Invited Seminars/Lectures, Salt-Sensitive Hypertension, Fourth Congress of Argentine Society of Hypertension, Buenos Aires, Argentina1996
National and International Invited Seminars/Lectures, Career Opportunities in the Medical School Basic Science Departments, Experimental Biology 1995, Atlanta, Georgia1995
National and International Invited Seminars/Lectures, Hypertension: Causes and Consequences of Renal Injury, Barcelona, Spain1995
Invited Symposia, Insulin Resistance and Hypertension, Philadelphia, Pennsylvania1995
National and International Invited Seminars/Lectures, Insulin Resistance and Hypertension in the Elderly, 3rd International Congress on Hypertension in the Elderly, Rome, Italy1995
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Tennessee, Memphis, Tennessee1995
National and International Invited Seminars/Lectures, Mechanisms of Obesity Associated Hypertension and Relevance to Essential Hypertension, International Congress of Nephrology, Madrid, Spain1995
National and International Invited Seminars/Lectures, Mechanisms of Obesity Hypertension and Their Relevance to Human Essential Hypertension, London Cardiovascular Society, London, Ontario, Canada1995
National and International Invited Seminars/Lectures, Obesity and Hypertension, Brookhaven National Laboratory, Montreal, Canada1995
National and International Invited Seminars/Lectures, Obesity, Insulin Resistance and Hypertension, North American Society for the Study of Obesity Annual Meeting, Baton Rouge, Louisiana1995
National and International Invited Seminars/Lectures, Pathophysiological Aspects of the Relationship Between Hypertension and Obesity, Spanish Society for Hypertension, Madrid, Spain1995
State/Local Invited Seminars/Lectures, Pathophysiology of Obesity Hypertension, Amylin Pharmaceuticals, Inc., San Diego, California1995
Regional Invited Seminars/Lectures, Physiological Mechanisms of Salt Sensitivity, Consortium of Southeastern Hypertension Centers, 2nd Annual Meeting, Charleston, South Carolina1995
National and International Invited Seminars/Lectures, Renal Mechanisms of Hypertension: Role of Obesity and Sodium, Brookhaven National Laboratory, New York, New York1995
State/Local Invited Seminars/Lectures, The Renin-Angiotensin System: Normal Physiology and Role in Hypertension, Symposium on "Angiotensin Receptor (ATI) Blockers", Jackson, MS1995
Invited Symposia, Insulin Resistance Syndrome: Role in a Panoply of Disorders, The Endocrine Society, 76th Annual Meeting, Anaheim, California1994
Invited Symposia, Insulin Resistance, Obesity, and Hypertension, Experimental Biology 1994, Anaheim, California1994
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Missouri School of Medicine, Columbia, Missouri1994
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Texas Health Sciences Center, San Antonio, Texas1994
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Louisville, Louisville, Kentucky1994
National and International Invited Seminars/Lectures, Neurohumoral and Renal Mechanisms of Obesity Hypertension, President's Symposium, American Society of Hypertension, New York, New York1994
National and International Invited Seminars/Lectures, Obesity Hypertension, the Renal Mdulla and the Renal Nerves, Hypertension Investigators Meeting, Amelia Island, Florida1994
Regional Invited Seminars/Lectures, The Kidney and Hypertension, Consortium of Southeastern Hypertension Centers Symposium, Asheville, North Carolina1994
Regional Invited Seminars/Lectures, Cellular and Molecular Mechanisms in Atherosclerosis and Hypertension, Fourteenth Annual Meeting of the Southeastern Pharmacology Society, Memphis, Tennessee1993
National and International Invited Seminars/Lectures, Insulin Resistance and Hypertension, Inter-American Society of Hypertension, San Diego, California1993
National and International Invited Seminars/Lectures, Insulin Resistance and Sympathetic Activity in Arterial Hypertension, Spanish Foundation for Cardiovascular Research, Madrid, Spain1993
Invited Symposia, International Symposium on ACE Inhibition, Amsterdam, the Netherlands1993
National and International Invited Seminars/Lectures, Interrelationships between Hyperinsulinemia, Hypertension and Diabetes, Including its Renal and Vascular Complications, American Society of Hypertension, New York, New York1993
State/Local Invited Seminars/Lectures, Invited Lecture, Parke-Davis Pharmaceutical Research, Cardiovascular Pharmacology Department, Ann Arbor, Michigan1993
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Nephrology, Utrecht University, Utrecht, the Netherlands1993
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Physiology, Tulane University, New Orleans, Louisiana1993
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Physiology, University of Murcia School of Medicine, Murcia, Spain1993
State/Local Invited Seminars/Lectures, Hypertension in Theory and in Practice, Jackson, MS1992
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Arkansas, Little Rock, Arkansas1992
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Medical Physiology, Texas A&M University, College Station, Texas1992
State/Local Invited Seminars/Lectures, John Whitney Memorial Medical Lecture, University of Arkansas Medical School, Little Rock, Arkansas1992
National and International Invited Seminars/Lectures, Kidney Function and Hypertension, 29th Meeting of Japanese Society of Applied Physiology, Gifu, Japan1992
National and International Invited Seminars/Lectures, Lewis K. Dahl Memorial Lecture, American Heart Association, New Orleans, Louisiana1992
Forum, Nephrology Forum, Kidney International, Boston, Massachusetts1992
National and International Invited Seminars/Lectures, Nephrology Research Conference, New England Medical Center, Tufts University, Boston, Massachusetts1992
National and International Invited Seminars/Lectures, Obesity, Hyperinsulinemia and Hypertension, Hypertension Society of Mexico, State of the Art Lecture, Mexico City, Mexico1992
Invited Symposia, Renal Excretory Function and Hypertension, Hypertension Investigators' Symposium, Amelia Island, Florida1992
National and International Invited Seminars/Lectures, The Kidney in Hypertension, Hypertension Society of Mexico, Mexico City, Mexico1992
National and International Invited Seminars/Lectures, Insulin and Hypertension, American Society of Hypertension, New York, New York1991
State/Local Invited Seminars/Lectures, Invited Lecture, Bristol-Meyers Squibb Pharmaceutical Group, Princeton, New Jersey1991
State/Local Invited Seminars/Lectures, Invited Lecture, The University of Iowa College of Medicine, Department of Internal Medicine, Iowa City, Iowa1991
Invited Symposia, Mechanisms of Endocrine Hypertension, American Physiological Society, San Antonio, Texas1991
Workshop, Nutrition and Hypertension, National Institutes of Health, Washington, DC1991
National and International Invited Seminars/Lectures, Obesity and Hypertension, American Society of Nephrology, Baltimore, Maryland1991
State/Local Invited Seminars/Lectures, The Kidney, Obesity and Essential Hypertension, Jackson, Mississippi1991
Invited Symposia, Treatment Considerations in the Mature and Elderly Hypertensive Patient, West Penn Hospital, Pennsylvania1991
Invited Symposia, ACE Inhibition in the 1990's, Napa, California1990
State/Local Invited Seminars/Lectures, Invited Lecture, Merck, Sharp & Dohme Research Laboratories, West Point, Pennsylvania1990
Invited Symposia, What is the Mechanism of One-Kidney, One-Clip Hypertension and its Relevance to Low-Renin Essential Hypertension?, American Society of Hypertension, New York, New York1990
Invited Symposia, ACE Inhibition in the 1990's and Clinical Trial Results with the New Agent Benazepril, West Palm Beach, Florida1989
National and International Invited Seminars/Lectures, Biological Responses to Prolonged Increase in Atrial Natriuretic Factor, Federation of American Societies of Experiemental Biology and Medicine, New Orleans, Louisiana1989
Invited Symposia, International Symposium on ACE Inhibition, London, England1989
State/Local Invited Seminars/Lectures, Invited Lecture, The Squibb Institute for Medical Research, Princeton, New Jersey1989
State/Local Invited Seminars/Lectures, Invited Lecture, University of South Carolina, Division of Nephrology, Charleston, South Carolina1989
State/Local Invited Seminars/Lectures, Invited Lecture, der Universitat Heidelberg, I. Physiologisches Institut, Heidelberg, Germany1989
National and International Invited Seminars/Lectures, Mechanisms of Sodium Homeostasis, Copenhagen, Denmark1989
National and International Invited Seminars/Lectures, Renal Hemodynamics: Integrative and Cellular Mechanisms, FASEB Summer Conference, Saxtons River, Vermont1989
National and International Invited Seminars/Lectures, The Renin-Angiotensin System in Volume and Pressure Homeostasis, International Congress of Physiological Sciences Symposium, Helsinki, Finland1989
Invited Symposia, Hypertension in the Aging Patient, American Geriatrics Society, Anaheim, California1988
National and International Invited Seminars/Lectures, Hypertension Research Symposium, University of Tennessee, Memphis, Tennessee1988
State/Local Invited Seminars/Lectures, Invited Lecture, Nephrology Research and Training Center, University of Alabama-Birmingham, Birmingham, Alabama1988
State/Local Invited Seminars/Lectures, Invited Lecture, Abbott Laboratories, Research Division, Abbott Park, Illinois1988
State/Local Invited Seminars/Lectures, Invited Lecture, Cardiovascular and Hypertension Center, The New York Hospital- Cornell Medical Center, New York, New York1988
State/Local Invited Seminars/Lectures, Invited Lecture, Mayo Clinic Fellows' Visiting Faculty, Rochester, Minnesota1988
National and International Invited Seminars/Lectures, The Intrarenal Circulation, American Society of Hypertension, New York, New York1988
State/Local Invited Seminars/Lectures, Invited Lecture, DuPont Experimental Station, Wilmington, Delaware1987
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, University of Cincinnati School of Medicine, Cincinnati, Ohio1987
State/Local Invited Seminars/Lectures, Invited Lecture, The University of Texas Health Science Center, School of Medicine, San Antonio, Texas1987
National and International Invited Seminars/Lectures, Vasopressin, Fluid- Electrolyte Regulation, Second International Vasopressin Conference, Smugglers Notch, Vermont1987
National and International Invited Seminars/Lectures, Hormones and Fluid Balance, International Union of Physiological Sciences, XXX International Congress, Vancouver, Canada1986
Regional Invited Seminars/Lectures, Invited Lecture, Toronto Society of Hypertension, Toronto, Canada1986
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin1986
State/Local Invited Seminars/Lectures, Invited Lecture, Louisiana State University School of Medicine, Shreveport, Louisiana1986
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, The University of Tennessee Health Science Center, Memphis, Tennessee1986
State/Local Invited Seminars/Lectures, Invited Lecture, DuPont Experimental Station, Wilmington, Delaware1986
National and International Invited Seminars/Lectures, Neurohormonal Regulation of Water and Electrolyte Balance: Neural and Hormonal Control of Kidney Functions, American Physiological Society, New Orleans, Louisiana1986
National and International Invited Seminars/Lectures, Physiological Role of the Intrarenal Renin-Angiotensin System, Federation of American Societies for Experimental Biology, Anaheim, California1985
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, Mayo Medical School, Rochester, Minnesota1984
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Texas College of Osteopathic Medicine, Fort Worth, Texas1984
State/Local Invited Seminars/Lectures, Invited Lecture, Pfizer Central Research Group, Groton, Connecticut1984
National and International Invited Seminars/Lectures, New Concepts of Blood Pressure Regulation, Federation of American Societies for Experimental Biology, St. Louis, Missouri1984
Invited Symposia, The Adrenal Gland and Hypertension, Satellite Symposium of the International Society of Hypertension, Padova, Italy1984
National and International Invited Seminars/Lectures, The Renal Origin of Hypertension: Progress over 50 Years, Council of High Blood Pressure Research of the American Heart Association, Toledo, Ohio1984
State/Local Invited Seminars/Lectures, Invited Lecture, Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Melbourne, Australia1983
Invited Symposia, The Kidney in Essential Hypertension, Alton Oscher Medical Foundation, New Orleans, Louisiana1983
National and International Invited Seminars/Lectures, Intrinsic Regulation of Renal Hemodynamics, American Physiological Society, Cincinnati, Ohio1981
National and International Invited Seminars/Lectures, Renal Hemodynamics, Eighth International Congress of Nephrology, Athens, Greece1981
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Michigan State University, East Lansing, Michigan1979
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Hypertension, Cleveland Clinic, Cleveland, Ohio1976

Honors, Awards, and Recognition

Arthur C. Guyton Award and Lecture, Association of Chairs of Departments of Physiology2019
Carl G. Evers Basic Science Professor of the Year, UMMC Medical Students2017
The Clifford V. and Drusilla R. Harding Lecture, Oakland University2016
Basic and Clinical Sciences, for Guyton and Hall Textbook of Medical Physiology, 13th edition, British Medical Association2016
Thomas G. Muldoon Memorial Lectureship, Medical College of Georgia, Augusta University2016
Ray G. Daggs Award, American Physiological Society, “for distinguished service to the Society and to the science of physiology”2016
Scholar Award, Distinguished Lecture Series, Texas A&M University2016
2015 Distinguished Service Award, Association of Chairs of Departments of Physiology2015
American Heart Association Award of Meritorious Achievement, for “For significant, long-lasting scholarly contributions, leadership and mentorship in the field of hypertension, including ten years as a highly successful Editor-in-Chief of the AHA journal Hypertension and 30 years as a vital leader for the Council on Hypertension, American Heart Association2015
Visitante Ilustre de Facultad de Medicina, National University of Tucumán2015
John D. Bower M.D. Distinguished Lectureship, University of Virginia School of Medicine, Division of Nephrology2015
Joy Goodwin Distinguished Lectureship, Auburn University2015
Distinguished Membership Award, for “Outstanding service and unusually distinguished contributions to experimental and clinical research in hypertension”, International Society of Hypertension2014
2014 Professor of the Year Award (selected for outstanding contributions to research, education and service from over 50,000 faculty members in SEC schools), Southeastern Conference2014
2014 Faculty Achievement Award, Southeastern Conference, University of Mississippi2014
Distinguished Alumni Award and Inductee into Hall of Fame, Kent State University, College of Education, Health and Human Services2013
Sir George Pickering Distinguished Lecture, British Hypertension Society2013
Doctor Honoris Causa, Grigore T. Popa Universitatea De Medicina Si Farmacie, Iasi, Romania2013
Excellence Award and Inductee into Mississippi Innovators Hall of Fame, Mississippi Technology Alliance2012
Franz Volhard Award and Lecture for Outstanding Research, International Society of Hypertension2012
Dr. Joseph Dvorkin Memorial Lecture, University of Alberta Cardiovascular Research Centre2010
J.O. Davis Graduate Student Distinguished Lecturer, University of Missouri at Columbia, College of Medicine2010
Lifetime Achievement Award, Inter-American Society of Hypertension2009
Executive Council, International Society of Hypertension2008
Presidential Lecture, Canadian Society of Hypertension2007
Norman C. Nelson Order for Teaching Excellence, University of Mississippi Medical Center2007
Mayerson/DiLuzio Memorial Lecture, Tulane School of Medicine2006
British Medical Association Book Competition Award, for Textbook of Medical Physiology, 11th edition, British Medical Association, Basic and Clinical Sciences2006
2005 Distinguished Achievement Award, American Heart Association, Council for High Blood Pressure Research2005
Carl G. Evers "All Star" Professor, University of Mississippi Medical Center Student Body2005
A. Ross McIntyre Award and Lecture, University of Nebraska Medical Center2005
Executive Council and Treasurer, International Union of Physiological Science2005
Lifetime Achievement Award, Consortium of Southeastern Hypertension Centers2003
Carl G. Evers "All Star" Professor, University of Mississippi Medical Center Student body2003
Michael J. Hack Memorial Lecture, Medical College of Wisconsin2003
Editor-in-Chief, Hypertension Journal, American Heart Association2002
Executive Scientific Council, International Society of Hypertension2002
Novartis Award for Hypertension Research, Council for High Blood Pressure Research, American Heart Association2002
President, Inter-American Society of Hypertension2001
President, The American Physiological Society2001
Visiting Professor in Basic Medical Sciences, Burroughs Wellcome Fund2000
Richard Bright Award, American Society of Hypertension2000
Chair, Council for High Blood Pressure Research, American Heart Association1998
Ernest H. Starling Award and Distinguished Lecturer, The American Physiological Society1998
Robert Tigerstedt Lifetime Achievement Award, Merck, Sharp & Dohme, International Society of Hypertension1998
Pfizer Distinguished Lectureship, Clinical Research Institute of Montreal, Canada1998
Billy S. Guyton Distinguished Professor, University of Mississippi Medical Center1996
Editor-in-Chief, American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, The American Physiological Society1996
Chair, Section Advisory Committee, The American Physiological Society1996
Special Research Achievement Award, American Heart Association, Mississippi Affiliate1996
Executive Council, American Society of Hypertension1995
Frederick A. P. Barnard Distinguished Professor, University of Mississippi1993
Treasurer and Executive Council, Inter-American Society of Hypertension1993
John E. Whitney Memorial Award and Lecture, University of Arkansas1992
Lewis K. Dahl Award and Lectureship, American Heart Association1992
Chairman, Water & Electrolyte Homeostasis Section, The American Physiological Society1991
Elected to Executive Council, The American Physiological Society1991
Marion Young Scholar Award, The American Society of Hypertension1988
Harry Goldblatt Award in Cardiovascular Research, Council for High Blood Pressure Research, American Heart Association1984
Travel Grant Award, American Society of Nephrology, 9th International Congress of Nephrology, Los Angeles, California1984
Travel Grant Award, American Physiological Society, 9th Congress of International Union of Physiological Sciences, Sidney, Australia1983
Travel Grant Award, American Society of Nephrology, 8th International Congress of Nephrology, Athens, Greece1981
Elected Fellow, Circulation Group, American Physiological Society1980
Elected Fellow, Council for High Blood Pressure Research, American Heart Association1980
Research Career Development Award, National Institutes of Health1979
Ernest G. Spivey Research Award, American Heart Association, Mississippi Affiliate1979
Research Service Award, National Institutes of Health1975
Title IV Predoctoral Fellow Award, NDEA1970
Award for scholastic achievement, Phi Delta Kappa1968
Magna Cum Laude Graduate, Kent State University1968
Deans List for academic achievement, Kent State University1964

Committee Service

Vice Chancellor's Research Advisory Committee, Member2013 - Present
MEDICAL CENTER-MARKETING, Member2012 - 2014
MEDICAL CENTER-DIVERSITY, Member2012 - 2014
Biomedical Research Grants Committee, Member2012 - 2013
Search Committee for Obesity Center Director, Chair2012 - 2013
MEDICAL CENTER-CANCER INSTITUTE INTERNAL ADVISORY, Vice Chair2012 - 2013
Chief Development Officer Search Committee, Member2011 - 2012
School of Pharmacy Research Awards Committee, Member2011 - Present
UMMC/VA Affiliation Partnership Council, Member2011 - 2014
Institutional Advisory Board, Mississippi Institute for the Improvement of Geographic Minority Health, Member2010 - 2013
MEDICAL CENTER-MASTER PLANNING, Member2009 - 2014
MEDICAL CENTER-MASTER PLANNING, Member2009 - 2014
Pediatrics Chair Search Committee, Member2009 - 2011
UMMC Vice Chancellor for Health Affairs Search Committee, Member2009 - 2010
Committee for Selection of Billy S. Guyton Professors, Member2009 - 2009
MEDICAL CENTER-SACS LEADERSHIP, Member2008 - 2014
Institutional Enhancement Committee, Member2007 - 2013
Conflict of Interest Committee, Member2006 - 2013
MEDICAL CENTER-SPACE, Member2006 - 2014
Search Committee for UMMC Cancer Insititute Director, Vice Chair2006 - 2009
Facilities Strategic Planning Committee, Member2006 - 2008
Human Resources Strategic Planning Committee, Member2006 - 2008
Advisory Committee, Development Director2006 - 2007
Science and Medicine Advisory Committee, Delta Health Alliance, Chair2006 - 2007
MEDICAL CENTER-ANIMAL CARE AND USE, Ex-Officio Member2005 - 2013
Biomedical Research Grants Committee, Chair2005 - 2012
Cancer Institute Steering Committee, Vice Chair2005 - 2013
Compliance Subcommittee for Research, Chair2005 - 2013
MEDICAL CENTER-INSTITUTIONAL COMPLIANCE, Member2005 - 2013
MEDICAL CENTER-LIBRARY FACULTY ADVISORY, Member2005 - 2011
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Chair2004 - 2004
MEDICAL CENTER-RESEARCH ADVISORY, Chair2003 - 2013
Internal Advisory Board, Center of Excellence in Women's Health, Member2003 - 2008
Search Committee for UMMC Development Director, Member2003 - 2004
Internal Advisory Board, Center of Psychiatric Neurosciences, Member2002 - Present
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member2000 - 2003
Dean's Graduate Research Award Selection Committee, Member1998 - 2009
Dean's Graduate Scholarship Selection Committee, Member1998 - 2009
Jackson Heart Study Scientific Directions Committee, Chair1998 - 2003
Jackson Heart Study Protocol Development Committee, Chair1998 - 1999
Steering Committee, Sesquicentennial Campaign, Member1998 - 1998
Long Range Planning Committee, Member1996 - 2013
Research Advisory/Development Committee, Member1996 - 2013
Biomedical Research Grants Committee, Member1996 - 2005
American Cancer Society Institutional Research Grants Committee, Member1996 - 1996
Howard Hughes Institutional Research Grants Committee, Member1996 - 1996
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Chair1994 - 1994
SCHOOL OF DENTISTRY-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member1994 - 1998
Transfusion Medical Education Advisory Committee, Member1990 - 2000
Anesthesiology Chair Search Advisory Search Committee, Member1990 - 1990
School of Dentistry, Executive Faculty, Member1989 - Present
SCHOOL OF MEDICINE-EXECUTIVE FACULTY, Member1989 - Present
Basic Science Promotions Committee, Member1989 - 2008
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member1989 - 1993
Neurology Chair Search Advisory Committee, Member1989 - 1989
Surgery Chair Search Advisory Committee, Member1989 - 1989
SCHOOL OF GRADUATE STUDIES IN THE HEALTH SCIENCES-GRADUATE COUNCIL, Member1980 - Present

Other Service

Institutional Cost Reduction Task Force, Member2009 - 2009
Pediatrics Chair Search Advisory Committee, Member2009 - Present
Search committee for Obesity Center Director, Chair2009 - Present
UMMC Vice Chancellor for Health Affairs Search Committee, Member2009 - 2010
Committee for Selection of Billy S. Guyton Professors, Member2009 - 2009
Institutional Quality Board, Member2008 - 2009
Institutional Enhancement Committee, Member2007 - Present
University of Mississipi Medical Center Research Foundation, Vice President2006 - 2013
Search Committee for UMMC Cancer Institute Directo, Co-Chair2006 - 2009
Facilities Strategic Planning Committee, Member2006 - 2008
Human Resources Strategic Planning Committee, Member2006 - 2008
Development Director Advisory Search Committee, Member2006 - 2007
Science and Medicine Advisory Committee, Delta Health Alliance, Chair2006 - 2007
Biomedical Research Grants Committee, Chair2005 - Present
Compliance Subcommittee for Research, Chair2005 - Present
Institutional Animal Care and Use Committee, Ex-Officio member2005 - Present
Internal Advisory Board, Center of Excellence in Women’s Health, Member2003 - 2008
Research Strategic Task Force, Chair2003 - 2004
Search Committee for UMMC Development Director, Member2003 - 2004
Research Council, Department of Medicine, Member2001 - 2009
Dean's Graduate Research Award Selection Committee, Member1998 - Present
Dean's Graduate Scholarship Selection Committee, Member1998 - Present
Jackson Heart Study Scientific Directions Committee, Chair1998 - 2003
Jackson Heart Study Protocol Development Committee, Chair1998 - 1999
Steering Committee, Sesquicentennial Campaign, Member1998 - 1998
Biomedical Research Grants Committee, Member1996 - Present
Research Development Committee, Member1996 - Present
American Cancer Society Institutional Research Grants Committee, Member1996 - 1996
Howard Hughes Institutional Research Grants Committee, Member1996 - 1996
Transfusion Medical Education Advisory Committee, Member1990 - 2000
Anesthesiology Chair Search Advisory Search Committe, Member1990 - 1990
Surgery Chair Search Advisory Committee, Member1990 - 1990
Neurology Chair Search Advisory Committee, Member1989 - 1989
AHA, Council for High Blood Pressure Research, Fellow1980 - Present
Graduate Program in Physiology and Biophysics, Director1980 - 1990
Participant, American Heart Association Research Summit2012

Teaching Experience

611, Medicine, Course, Course Director, PHYS 2012
611, Medicine, Course, Course Director, PHYS 2011
611, Medicine, Course, Course Director, PHYS 2010
611, Medicine, Course, Course Director, PHYS 2009
611, Medicine, Course, Course Director, PHYS 2008
611, Medicine, Course, Course Director, PHYS 2007

Directed Student Learning

Supervised Research, Advised: Benjamin Pace2011 - Present
Supervised Research, Advised: Corey Parish2011 - 2011
Summer Research Volunteer, Advised: Ahmad Adi2010 - 2010
Supervised Research, Advised: Ahmad Adi2010 - 2011
Supervised Research, Advised: John Rushing2010 - 2011
Supervised Research, Advised: Mark Davis2009 - Present
Supervised Research, Advised: Benjamin Pace2009 - 2010
Supervised Research, Advised: Mark Davis2009 - 2010
Supervised Undergraduate Research, Advised: Jarrett Morgan2009 - 2009
Advisor, Advised: Mark Davis2008 - 2008
Advisor, Advised: Gray Wallace2007 - 2007
Supervised Research, Advised: Nathan Freeman2006 - 2011
Summer Research Program, Advised: John (Barr) Biglane2006 - 2006
Summer Research Program, Advised: Lauren Cantwell2006 - 2006
Thesis Advisor, Advised: Wendy Case2006 - 2006
Supervised Research, Advised: John (Barr) Biglane2006 - 2006
Supervised Research, Advised: Lauren Cantwell2006 - 2006
Supervised Undergraduate Research, Advised: Joshua Lasseigne2005 - 2005
Supervised Undergraduate Research, Advised: Tracie Perkins2005 - 2005
Supervised Research, Advised: Brittany Penland2005 - 2005
Supervised Research, Advised: John V. Roberts2005 - 2005
Supervised Research, Advised: Lila Hudson2004 - 2005
Supervised Undergraduate Research, Advised: Elizabeth Fowler2004 - 2004
Supervised Undergraduate Research, Advised: Paul Brown2004 - 2004
Supervised Research, Advised: Mary Alissa Willis2004 - 2004
Supervised Undergraduate Research, Advised: Amel Mohamed2003 - 2003
Supervised Undergraduate Research, Advised: Chiatne McFarland2003 - 2003
Supervised Undergraduate Research, Advised: James Arthur Burwell II2003 - 2003
Major Advsior, The Role of NA+-K+2CI- Cotransporter 1 in Cerebral Artery Contraction and in Neonatal Hypoxia-Ischemia
Advised: Yun Dai
2003 - 2003
Dissertation Committee Member, Involvement of Mitogen- Activated Protein Kinase in the Pathogenesis of Cerebral Vasospasm
Advised: Alexander Zubkov
2001 - 2001
Supervised Undergraduate Research, Advised: Allison Hailman2000 - 2002
Supervised Undergraduate Research, Advised: Leigh Ammons2000 - 2002
Supervised Undergraduate Research, Advised: Melanie Hand2000 - 2000
Supervised Undergraduate Research, Advised: Megan Carlyle1999 - 2000
Supervised Research, Advised: O. Barrett Jones1999 - 2000
Dissertation Committee Chair, Role of Potassium in Protecting Against Arteriosclerosis and Neointimal Lesion Formation
Advised: Ge Ma
1999 - 1999
Dissertation Committee Member, Advised: Jan ter Maaten1999 - 1999
Supervised Undergraduate Research, Advised: Joel Paul Martin1999 - 1999
Supervised Undergraduate Research, Advised: LeShawn McNair1999 - 1999
Supervised Undergraduate Research, Advised: Monica Davis1999 - 1999
Supervised Research, Advised: Matthew Verucchi1999 - 1999
Supervised Undergraduate Research, Advised: Kim Anderson1998 - 1999
Supervised Research, Advised: Glenn (Andy) Brien1998 - 1999
Supervised Undergraduate Research, Advised: Lafarra Young1998 - 1998
Supervised Research, Advised: Omar Logue1998 - 1998
Supervised Research, Advised: Paul Kim1998 - 1998
Dissertation Committee Member, Mechanisms of Insulin Hypertension in Rats
Advised: Henry Keen
1997 - 1997
Supervised Research, Advised: William Hewitt1997 - 1997
Supervised Undergraduate Research, Advised: Clifton R. Barker1996 - 1997
Dissertation Committee Member, Interaction Between Intrarenal Nitric Oxide and the Renin-Angiotensin System in the Control of Kidney Function and Blood Pressure
Advised: Christine Schnackenber
1996 - 1996
Dissertation Committee Member, Adaptation of Blood Vascular System to Maximum Metabolic Demand
Advised: Jian Hang
1995 - 1995
Dissertation Committee Member, Renal and Cardiovascular Mechanisms of Obesity Hypertension
Advised: Magdalena Alonso-Galicia
1995 - 1995
Supervised Research, Advised: Timothy Hopkins1995 - 1995
Supervised Undergraduate Research, Advised: John Bradley Madden1994 - 1996
Dissertation Committee Member, Endothelium-derived Nitric Oxide and Arterial Pressure Regulation
Advised: Lufei Hu
1994 - 1994
Supervised Research, Advised: William Lee1994 - 1994
Supervised Research, Advised: Angela Gardner1993 - 1993
Supervised Research, Advised: David Harrison1993 - 1993
Supervised Research, Advised: Michael Holman1992 - 1992
Dissertation Committee Member, Role of Total Peripheral Resistance in the Long-Term Control of Arterial Blood Pressure and the Pathogenesis of Hypertension
Advised: Min Huang
1991 - 1991
Dissertation Committee Member, Effects of Acute Hyperkalemia on Renal Hemodynamics and Renal Secretion in Intact Animals
Advised: Huabao Lin
1990 - 1990
Dissertation Committee Member, Investigation of Canine Forelimb Arterial Vascular Pressure Gradients with Reference to the Ability of Peripheral Measurement Sites to Estimate the Parameters of the Central Aortic Pressure
Advised: A. William Paulsen
1989 - 1989
Dissertation Committee Member, Adrenergic Regulation of Renin Release and the Role of Angiotensin II in Mediating the Renal Actions of Norepinephrine
Advised: Hun Mo Yang
1989 - 1989
Dissertation Committee Member, Role of the Transvascular Fluid Flux and Lymph Flow in Extracellular Fluid Volume Regulation During Vasoconstrictor and Volume-loading Hypertension
Advised: Jorge Valenzuela-Williams
1989 - 1989
Dissertation Committee Member, Effects of Selective B2-Agonist on Circulatory Control Mechanisms in Dogs
Advised: Bahij Nuwayhid
1987 - 1987
Major Advisor, Role of the Renal Nerves in the Long Term Control of Renal Hemodynamics and Electrolyte Excretion
Advised: H. Leland Mizelle
1987 - 1987
Dissertation Committee Member, Analysis of the Cardiovascular Effects of Arginine Vasopressin in Dogs
Advised: Udom Tipayomontri
1984 - 1984
Dissertation Committee Member, Baroreceptor Gain, Arterial Pressure and Heart Rate in Arterial Baroreceptor Denervated and Spontaneously Hypertensive Rats
Advised: Ann Dent
1983 - 1983
Major Advisor, Control of Renal Hemodynamics, Electrolyte Excretion and Arterial Pressure: Role of the Kallikrein-Kinin System
Advised: Joey Granger
1983 - 1983
Dissertation Committee Chair, Reactive and Exercise Hyperemic During High Levels of Adenosine Infusion
Advised: Robert Hester
1982 - 1982
Dissertation Committee Member, Oxygen Consumption, Heart Rate, and Subjective Rating Under Conditions of Relaxation and Active Coping
Advised: James Hollandsworth
1982 - 1982
Dissertation Committee Member, Evaluation of Reflex Control of Arterial Pressure by Sinusoidal Blood Volume Changes in Baroreceptor Denervated and Baroreceptor Innervated Dogs
Advised: David Brown
1981 - 1981
Dissertation Committee Member, The Interaction of Volume and Osmoreceptors in the Control of Plasma Vasopressin, Body Fluid Volumes, and Electrolytes
Advised: Edmund Quillen
1981 - 1981
Dissertation Committee Member, Experimental Aldosterone Hypertension
Advised: Yi-Jen Pan
1979 - 1979
Dissertation Committee Member, The Pulmonary Circulation: Studies on Alveolar Hypoxia and Vascular Smooth Muscle Metabolism
Advised: Richard Parker
1978 - 1978
Supervised Research, Advised: Beth Mitcheltree-Miller
Supervised Research, Advised: Robert Meacham III
Supervised Research, Advised: William N. Dixon
Supervised Research, Advised: John E. Ammons
Supervised Research, Advised: Robert Stewart
Supervised Research, Advised: Andrew C. Brown
Supervised Research, Advised: Lee E. Herring
Supervised Research, Advised: Melynda Cummins
Supervised Research, Advised: Jennifer DeCrane
Supervised Research, Advised: S. Keith Rushing
Supervised Research, Advised: Ava H. Bell
Supervised Research, Advised: George M. Thurber
Supervised Research, Advised: Anthony E. Daniels
Supervised Research, Advised: Aubrey L. Scott
Supervised Research, Advised: Celia Lauren Morse
Supervised Research, Advised: Douglas N. Packer

Fellows supervised

University of Mississippi Medical Center Department of Physiology, Training Faculty, 34 fellows supervised, Hall Lab01/1976 - Present